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ABSTRACT 
Title: 
 A Clinical study on papulosquamous disorders in children less than 
12 years, 
Background and objectives 
 Among the wide spectrum of skin diseases in children, 
papulosquamous disorders form quite a common group. Papulosquamous 
disorders during childhood can present a vast array of clinical findings. 
This study was done to know the hospital based prevalence and the 
clinical patterns of papulosquamous disorders among children less than 
12 years  of age presenting to skin OPD, Coimbatore Medical College 
Hospital. 
Methodology 
 This is a descriptive study conducted from August 2013 to July 
2014 at the outpatient Department of Skin and STD, Coimbatore Medical 
College Hospital.105 consecutive children with papulosquamous disorder 
were included in the study. Routine investigations were done for all cases 
and special investigations like potassium hydroxide mount, culture and 
skin biopsy were done for relevant cases. 
Results 
 Papulosquamous disorders constituted 0.81%% of the pediatric 
dermatoses during the study. M: F ratio was 1.1:1.0. Majority of the 
patients belonged to 10-12years age group. Among papulosquamous 
disorders, psoriasis was the most common disease (25.7%), followed by 
pityriasisrosea (22.95%) and lichen planus(18.09%). 
CONCLUSION 
 Papulosquamous disorders are common in children and have varied 
presentations. Genetic inheritance of papulosquamous disorder is less 
significant. Papulosquamous disorders in children require a separate view 
from adult dermatoses as there are important differences in clinical 
presentation, treatment and prognosis.    By understanding the 
morphological characterestics of papulosquamous diseases and 
differentiating the diseases clinically , we can  explain the prognosis of 
the disease to the parents, which will alleviate their worry. 
KEY WORDS:  
 Papulosquamous, childhood, psoriasis, pityriasis rosea 
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INTRODUCTION 
Papulosquamous diseases are typically characterized by well-
demarcated areas of papules and scales typically on an erythematous 
background. Papulosquamous disorders form a common group among the 
wide spectrum of skin diseases in children.  The disease which comes 
under this group varies from the inflammatory skin disease like psoriasis 
to infections like syphilis and from self-resolving  pityriasis rosea to the 
treatment resistant parapsoriasis. 
The diseases which come under papulosquamous group mimic 
each other. Atypical presentations can be there in individual diseases. 
Diagnosing these  atypical variants clinically will save the time,resources 
and avoid procedures like biopsy in children. 
Children are not little adults.  A child’s skin is different from that 
of adults. The skin of children is thinner. They are more prone for 
damage from external insults.  Surface to volume ratio of child’s skin is 
greater than that of adults, so more amount of chemicals can be absorbed 
by them. 
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The presentation of the same disease may differ in children and 
adults. Prevalence of subtypes in the same disease will vary between 
adults and children. 
Though there are various studies on paediatric dermatosis and 
individual papulosquamous disorders, there is a paucity of studies 
regarding papulosquamous disorders in children.  
Thus studying the prevalence and clinical features of 
papulosquamous disorders in children helps dermatologists to understand 
better the papulosquamous disorders in children and to manage them 
appropriately. 
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AIM AND OBJECTIVES 
 
1. To study the prevalance of papulosquamous disorders in children 
less than 12 years of age 
2. To study the prevalence, age sex distribution, morphology of 
individual papulosquamous disorders in children less than 12 
years of age 
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REVIEW OF LITERATURE 
 
The  papulosquamous diseases,characterized by scaly papules or 
plaques, constitute the largest conglomerate group of disease seen by 
dermatologist. The word “Papule” is derived from the latin word papula 
which means pimple  and “scale”is derived from latin  words 
squames.The nosology of these disorders is based on a descriptive 
morphology of clinical lesions characterized by scaly papules and 
plaques
.1.
These diseases assume considerable importance because of their 
frequency of occurrence .Because all are characterized by 
papules,patches,plaques and scaling,clinical confusion may result in their 
differentiation. Separation of each of these disease becomes important 
because the treatment and prognosis for each tends to be  disease specific. 
In a study of pattern of pediatric dermatoses in 
Rajasthan,papulosquamous disorders constituted 1.66% of all the 
dermatoses.
2
In a  similar study in Saudi Arabia, papulosquamous 
disorders constituted 8.1% of all dermatoses.
3 
Papulosquamous disorders of children can present with various 
clinical manifestations. The frequency of distribution of papulosquamous 
disordes in children varies in different age groups also. For example 
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seborrheic dermatitis is relatively more common during early ages of life. 
Certain morphological types of these disorders will be more common in 
children than that of adults. Guttate psoriasis is more common in children 
than adults.  
The papulosquamous disorders have classic and distinct clinical 
features. But sometimes the morphology of the lesion will appear 
atypical.The diseases which are classified under papulosquamous 
disorder can present with non papular non scaly form also. For example, 
bullous lichen planus, purpuric pityriasis rosea and pustular psoriasis. 
Some of the diseases in this group are chronic and relapsing. This 
necessitates periodical examination of the children and  long term follow 
up. So parent education is an important for the better  management of 
these group of disorders. They should be advised regarding adherence to 
the treatment and avoidance of the trigerring factors such as minor 
trauma. 
Various authors have included different set of disorders in their 
study of papulosquamous disorders. 
Gibson et al , perry H.O  considered Psoriasis, Pityriasis Rubra 
Pilaris, Pityriasis Rosea, Lichen Planus, Lichen Nitidus , lichen striatus 
and parpsoriasis in their study.
4
 Toussaint S. and Kamino H considered 
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the same set of diseases in their study.
5
 But Hall,
6
includedpsoriasis, 
Pityriasis rosea,Lichen Planus, tinea versicolor,  seborrheic dermatitis, 
secondary syphilis and drug eruptions in his study. 
ICD classification of papulosquamous disorders
7
 
Psoriasis  
• Psoriasis vulgaris 
• Generalized pustular psoriasis 
• Impetigo herpetiformis 
• Von zumbusch’s disease 
• Acrodermatitis continua 
• Pustulosis Palmaris et plantaris 
• Guttate psoriasis 
• Arthropathic psoriasis 
• Other psoriasis 
• Psoriasis.unspecified 
Parapsoriasis   
• Pityriasis lichenoides et varioliformis acuta 
• Mucha habermann disease 
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• Pityriasis lichenoides chronica 
• Lymphomatoid papulosis 
• Small plaque parapsoriasis 
• Large plaque parapsoriasis 
• Retiform parapsoriasis 
• Other parapsoriasis 
• Parapsoriasis unspecified  
Pityriasis rosea 
Lichen planus 
Other papulosquamous disorders 
• Pityriasis rubra pilaris 
• Lichen nitidus 
• Lichen striatus 
• Lichen ruber moniliformis  
• Infantile papular  acrodermatitis(Gianotti-Crosti syndrome) 
• Other specified papulosquamous disorders  
• Papulosquamous disorder ,unspecified 
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Papulosquamous disorders in disease classified elsewhere 
Psoriasis 
 Psoriasis is a  common, chronic, disfiguring, inflammatory and 
proliferative condition of the skin, in which both genetic and 
environmental influences have a critical role.
8
 It is  characteristized by 
red, scaly, sharply demarcated, indurated plaques, present particularly 
over extensor surfaces and scalp. The disease is enormously variable in 
morphology, duration, periodicity of flares, severity and extent. Plaque 
psoriasis is the  most frequent type in children, as in adults. However 
initial lesions are often smaller, thinner and less scaly.
9
When compared to 
adults certain clinical variants like erythroderma, arthropathy, and 
localized and generalized pustular psoriasis are rare in children.
10 
Epidemiology  
A definitive paucity of studies existson the epidemiological 
background  of childhood psoriasis. Psoriasis accounts for about 4% of all 
dermatoses in children less than 16yrs of age and occurs at all ages in 2-
3% of the population.
11,12
 
Psoriasis constituted 3.4% of all skin disorders in a study 
conducted in  Kashmir
13
. A study from south India in children less than 
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14 years showed a prevalence of 1.4%.
14
 A prospective study in Kuwait 
showed a prevalence of 4% among  paediatric dermatoses.
15
In a study 
conducted at Saudi Arabia over a period of 24 months psoriasis 
constituted about 22.6% among the papulosquamous disorders in children 
less than 13 yrs.
3 
About 31-45% of adults with psoriasis have noted the onset during 
first two decades of life. As much as 40% of adult patients with psoriasis 
have reported manifestations of psoriasis  in childhood, with at least one-
third of the patients demonstrating features of psoriasis before the age of 
16.1 years.
17
. A study conducted in north India showed, the average age 
of onset of psoriasis in boys is 6-10years and that of girls is 10-14 years.
18 
Psoriasis has been reported to be more common in girls.
19
 However 
Nanada et al observed an equal gender distribution in childhood
20
 which 
is similar to results of Morris et al
21
 and Kumar et al
18
  studies.
 
Seventy percentage of affected paediatric population have a family 
history of psoriasis and affected twins have been described.
22
 But history 
of occurrence  in the  family varies in different races. A study conducted 
in north India showed a positive family history of 4.5% among 
children.
18
A study conducted in China also showed a family history of 
only 8%.
23
 But a study conducted in United States showed a family 
  
10 
 
history of  51.4%.
24
The lifetime risk of developing psoriasis is thought to 
be 4% if no parent is affected,28% if one parent is affected and 65% if 
both parents are affected. 
25 
Chronic plaque type psoriasis is the most common presentation in 
children which is similar to adults. Guttate psoriasis is more common in 
children. The severity of the condition may vary from mild localized 
disease to life threatening neonatal pustular dermatoses or exfoliative 
dermatoses.
 
Etiopathogenesis
8 
Henseler and Christophers  demonstrated that the bimodal peak in 
disease onset  could be taken as evidence for the existence of two 
pathogenetically distinct forms of the disease, similar to the model for 
diabetes mellitus. Thus, type 1 is hereditary, strongly HLA associated 
(particularly HLA-Cw6), early onset and more likely to be severe. Type 
II is sporadic, HLA unrelated, of late onset and usually mild.Childhood   
psoriasis have more familial preponderance than adult onset psoriasis. 
Physical, chemical, electrical, surgical, infective and inflammatory 
insults have been recognized to trigger psoriatic lesions.Drugs like 
lithium, antimalarials, beta blockers, ACE Inhibitors, NSAIDs  are 
reported to be responsible for onset or exacerbation of psoriatic 
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lesions.Acute guttate psoriasis may be associated with past history of 
streptococcal throat infection. 
In general sunlight is beneficial to psoriatic lesions but in a minority of 
patients, psoriasis can be exacerbated by sunlight. 
In HIV infection, severity of psoriasis and incidence of psoriatic 
arthropathy will be more. 
Pathogenetic mechanism 
Pathogenesis of psoriasis can be explained by the following four 
factors; 
• Epidermal proliferation 
There is an increase in the proliferation of cells in the basal and 
suprabasal layers of epidermis. There is a sevenfold increase in the 
number of cycling cells. Transforming growth factor is an important 
mediator for keratinocyte proliferation.  
• Vascular changes  
Vascular growth or angiogenesis is an important factor in the 
pathogenesis of psoriasis. Immunohistochemical studies have shown that 
there is a fourfold increase in the endothelium of superficial dermis with a 
proliferating index of  3%. 
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In vivo models of angiogenesis have demonstrated that epidermal 
keratinocytes are the primary source for angiogenesis. These cells will 
produce various angiogenic factors including vascular endothelial growth 
factor. VEGF is overexpressed in psoriatic epidermis  and receptors are 
increased in psoriatic microvasculature. 
Inflammatory mediators like E cadherin and intercellular adheshion 
molecule (ICAM 1) is overexpressed in dermal capillaries of psoriatic 
skin, which cause accumulation of lymphocytes in  lesional epidermis 
and dermis. Other inflammatory mediators  which induce leukocyte 
homing in skin are histamine, neuropeptides, IL-1 and TNFα. 
• Molecular genetics  
Psors1, which is located within MHC on chromosome 6p  is the major 
psoriasis genetic determinant .It  accounts for about 35-50% of 
heritability of the disease. 
• Immunology and inflammation 
There is a dysregulation in the innate immune mechanism in 
psoriatic patients.  Innate immunomediators  like antimicrobial peptides 
are overexpressed in psoriatic lesions. This will lead to antigen driven T 
cell expansion and activation. The most important subsets that are 
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activated in  psoriasis are Th1 and Th17. Th17 clone of Tcells will 
overexpress IL23, which will induce psoriatic phenotype. Avtivated T 
cells will also secrete IFN gamma,  which causes keratinocyte 
proliferation. 
Histopathology
5,26 
A fully developed plaque of psoriasis will show hyperkeratosis 
with confluent parakeratosis. Stratum corneum will show micromunro 
abscess.spongiform pustules of Kogoj will be there in the stratum 
malphigi.. There will be hypogranulosis with regular acanthosis and  
Suprapapillary thinning of epidermis Dermis will show elongation and 
edema of dermal papillae with dilated tortuous dermal capillaries and 
lymphocytic infiltration. 
CLINICAL FEATURES  
Chronic plaque psoriasis 
This is the most common morphological variant of psoriasis seen 
in children. The lesions will be well defined erythematous plaques with 
easily removable silvery white   scales distributed over extensor aspect of 
knee, elbow and trunk.As compared to adults, in children the plaques are 
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often smaller and scales are finer and softer
27
. Children will have severe 
itching than adults.  
Removal of   scales over the plaque with a glass slide will reveal a 
red glistening membrane called Buckley’s membrane. Successive 
scraping of the plaque will produce fine punctate bleeding points. This 
phenomenon is called Auspitz sign. Koebnerisation is a process in which 
isomorphic cutaneous lesions develops at the line of trauma. Koebner 
phenomenon can develop at the sites of trauma in psoriasis. 
Facial involvement is more common in children than adults. It 
occurs in about 4-5% of patients. Periorbital area is the most typical site 
affected.
27
 
Guttate psoriasis 
The term guttate psoriasis is derived from the Latin word gutta 
,which means  “a drop”. The lesions of guttate psoriasis will be 
erythematous papules and plaques which vary from 2-3mm to 1cm with 
overlying silvery white scales, which are distributed almost 
symmetrically over trunk and proximal part of extremities. Guttate 
psoriasis  mostly occurs in children ,often a week after streptococcal 
pharyngitis. 
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Various studies have shown that about 40% of children with 
guttate psoriasis may progress to chronic plaque psoriasis.
28
 
Scalp psoriasis
29
 
In children scalp is frequently the first affected site (20-40%). The 
lesions will be similar to that occurring in other parts of the body. The 
psoriatic lesion over the scalp and eyebrows can be greasy and more 
salmon coloured, often termed sebopsoriasis.  Lesions of  psoriasis 
frequently extend  beyond the hairline, to forehead, preauricular, 
postauricular and nuchal region. This feature of psoriasis is  in contrast to 
seborrheic dermatitis which confines to the hairline. 
Tinea amiantacea , also called as pityriasis amiantacea is a variant 
of scalp psoriasis occurring in children, which is characterized by large 
plates of firmly adherent scales(asbestos –like) on scalp and hair. It 
usually begins in childhood and about 2-15% may progress to more 
typical psoriasis. 
Flexural psoriasis  
Flexural psoriasis involves  groins, vulva , axillae, submammary 
folds, gluteal cleft and other body folds. It is more common in adults than 
in children. In children the most frequently affected area is napkin area 
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and axillae. It presents as sharply demarcated bright red plaques.  Scales 
may not be evident clinically but may be  revealed on gentle scrapping. 
Many infants with diaper area psoriasis may show psoriatic plaques in 
other regions. 
Nail psoriasis
29
 
Nail involvement is seen in 25-50% of pediatric  patients with 
psoriasis. Pitting is the most common manifestation and other features 
like discolouration onycholysis, subungual hyperkeratosis, splinter 
haemorrhages can also be seen . Nail bed and hyponychium may show 
circular areas of discoloration, which resembles  an ‘oil drop’. Secondary 
infection with bacteria, candida and dermatophytes can be seen with 
increased frequency. Nail disease will be more severe if onset of psoriasis 
is early and familial. 
Erythrodermic psoriasis: 
27
 
 It is a severe variant   of psoriasis  characterised by generalised 
erythema and scaling. It accounts for about 16-24% of all cases of 
erythroderma cases.  It can develop in a patient with   pre existing chronic 
plaque psoriasis or as a manifestation of unstable psoriasis precipitataed 
by drugs, infection, steroid withdrawal or overuse of tar or dithranol. 
Erythrodermic psoriasis is relatively rare in chilren. 
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Pustular psoriasis 
 Classification of pustular psoriasis is
8
 
 1 Localized pustular psoriasis: 
 (a) palmoplantar pustulosis 
 (b) acrodermatitis continua 
2 Generalized pustular psoriasis: 
 (a) acute 
 (b) of pregnancy 
 (c) infantile and juvenile 
 (d) circinate 
 (e) localized (not hands and feet). 
Infantile and juvenile pustular psoriasis
8 
 Pustular psoriasis is a variant of  psoriasis described by Von 
zumbusch in 1910. In children, pustular psoriasis is very rare and 
accounts for about 1.1% of  childhood psoriasis. Average age of onset of 
pustular psoriasis in children is 2-10 years,but  cases with onset in the 
first year of life have  also been described. Two case of congenital 
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generalised pustular psoriasis have been reported. Male  preponderance is 
seen in childhood GPP with a ratio of 3:2. 
 Infantile pustular psoriasis is usually benign. Generally systemic 
symptoms are absent. Fever and symptoms of acute toxicity can develop 
in some  children. Annular and circinate forms are the most common 
presentations. Lesions begin as discrete areas of erythema, which become 
raised and oedematous. Pustules appear at the periphery which desiccate, 
leaving  a trailing fringe of scale as the lesion slowly advances.  Von 
zumbusch pattern also  be seen in children, which have an abrupt onset 
with features of toxicity. In older children the pattern will resemble that 
of adults. 
 The lesions will subside within few weeks but recurrent episodes 
can be there. Von zumbusch type can progress to erythroderma. The 
prognosis of pustular psoriasis in children is variable.  
Extracutaneous involvement 
29
 
 Arthritis :Psoriatic arthritis is biphasic in pediatric population. 
Younger children will present with dactylitis and small joint involvement. 
Most of them will be female children. The affected  fingers and toes will 
have a “sausage shaped” appearance due to the juxtaarticular swelling. 
Radiological examination of metatarsophalangeal and 
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metacarpophalangeal joint will show  “pencil-in-cup” or “pencil-and-
goblet” deformity. 
 Older children with psoriatic arthritis will have axial joint 
involvement and enthesitis. 
 A study of 211 children with moderate and severe psoriasis showed 
that 9% of affected children had joint involvement. 
 Uveitis:14-17% of children with psoriatic arthritis will have 
asymmetric  anterior uveitis . 
 Others :Recent studies have shown that there is a clear link 
between psoriasis and metabolic syndrome and cardiovascular risk. 
Studies in pediatric patients also showed that risk of obesity, 
cardiovascular complications begins in childhood and adolescence. 
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Differential diagnosis: 
Table 1:Differential diagnosis of psoriasis in childhood
30 
TYPE OF PSORIASIS DIFFERENTIAL DIAGNOSIS 
Psoriasis vulgaris Discoid eczema 
Tinea corporis 
SCLE 
Lichen simplex chronicus  
SPEK 
Cutaneous Tcell lymphoma 
Guttate psoriasis Pityriasis rosea  
Pityriasis lichenoides chronicus 
Lichen planus 
Secondary syphilis 
Drug eruption 
Flexural psoriasis Intertrigo  
Candidiasis  
Hailey-Hailey disease  
Erythrodermic psoriasis  Drug induced erythroderma 
PRP 
Eczema 
CTCL 
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Pustular psoriasis Impetigo 
Superficial candidiasis 
Subcorneaal pustular dermatosis 
Transient neonatal pustular melanosis 
Acropustulosis of infancy 
AGEP 
Scalp psoriasis Tinea capitis 
Atopic dermatitis 
Seborrheic dermatitis 
Nail psoriasis Tinea unguium 
Nail dystrophy 
Lichen planus 
 
Treatment 
31 
 Treatment of psoriasis in children is a therapeutic challenge. There 
is no definite guidelines for the management of  psoriasis in children and 
many therapeutic agents are  not approved for use in children. The aim of 
treatment of psoriasis is to control the disease and  improve the quality of 
life of the children. Success of treatment    depends on  compliance to the 
treatment  which can be enhanced by parent education about nature of 
disease and treatment options. 
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 Topical vitamin D analogue(calcipotriol and calcitriol) is an 
effective well tolerated treatment option for mild to moderate childhood 
psoriasis. Studies have shown that calcipotriol is safe and effective in 
treating childhood psoriasis ,involving<30% of body surface area. The 
maximum recommended dose is 50g/week/m
2 .
Vitamin D analogue 
induces differentiation of keratinocytes , inhibits their proliferation and 
inhibits immunological mediators in the pathogenesis of psoriasis. It 
should not be applied on the face,scalp,genital area and areas under 
occlusion. Hypercalcemia can result from application of large quantities. 
 Tacrolimus is an imunomodulator which inhibits calcineurin and 
prevents the production of inflammatory cytokines from T-cells. Topical 
0.1% tacrolimus is an effective treatment option for psoriasis over the 
face and intertriginous areas. 
 Guttate psoriasis and pustular psoriasis can be precipitated by 
streptococcal infections. So appropriate antibiotics can be given in these 
forms of psoriasis.Even tonsillectomy have been advised in recurrent 
pustular psoriasis. 
 Methotrexate can be used  in children with severe and extensive 
psoriasis. It will be more beneficial when psoriasis is associated with 
arthritis. Retinoids and ciclosporin are effective in pustular psoriasis. 
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Children on long term retinoids  are at a risk of premature epiphyseal 
closure. So they require radiological monitoring at an interval of 1 year. 
Hypertension,  nephrotoxicity,hypertrichosis and  gingival hyperplasia 
are the adverse effects of ciclosporin.Phototherapy can be used in 
extensive disease as an alternative to systemic treatment, but it has the 
potential side effect of carcinogenicity and premature ageing of the skin. 
 Biologicals play an important role in the treatment of childhood 
psoriasis which are resistant to topical and systemic therapy. TNF alpha 
blocking biologicals are etanercept, infliximab and  adalimumab . T cell 
targeting biologicals are efalizumab and abatacept.  Efalizumab 
,amonoclonal antibody directed against CD11a  was FDA approved for 
treatment of moderate to severe plaque psoriasis. Abatacept, a Tcell co 
stimulation modulator is used to treat psoriatic arthritis. 
Prognosis 
30 
 Guttate psoriasis in children is usually a self limiting disease, 
which resolves within 12-16 weeks. In contrast to this, chronic plaque 
psoriasis has a prolonged course with remission and exacerbation. The 
other variants like erythrodermic and psoriatic arthropathy have poor 
prognosis. The disease will be severe and persistent. 
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PITYRIASIS ROSEA 
 Pityriasis rosea is a common,self limiting skin eruption that 
typically begins as a single thin oval scaly plaque on the trunk, known as 
herald patch. The word pityriasis means scales and rosea means pink. 
Camille melchoir gibert coined the name and gave the accurate 
description of pityriasis rosea in 1860.
32
Alfred Blashko described 
peripheral scaling in 1899.  Emile vidal described pityriasis circinata et 
marginata in 1882.
33
 
Epidemiology: 
 The incidence of pytiriasis rosea ranges from 0.39
34
 to 4.8
35
 per 
100  dermatology cases. The incidence of  pityriasis rosea in paediatric 
patients is 1.02 per 100 patients.
36
 The prevalence of pityriasis rosea 
reported in adolescents is 0.6%. 
37 
 Most of the cases are seen between the ages of 10 and 35.
38
The 
youngest reported age of pityriasis rosea was 3 months.
39
It is very rare in 
those who are less than 2 years and more than 65 years. Male and female 
are affected equally. But various studies have shown a slight female 
preponderance of  approximately 1.5:1.
38,40 
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Aetiology 
 Pityriasis rosea is a disease of unknown origin. The natural course 
of the disease, prodromal symptoms, primary herald patch , secondary 
eruptions followed by complete remission suggests an infectious etiology. 
This is also strengthened by the observation of clustering of the disease in 
some communities.
41 
 Studies have shown that there is a relationship between pityriasis 
rosea and   HHV 6 and 7. Electron microscopic examination of lesional 
biopsies have shown evidence of human herpes virus DNA.
42 
HHV7  
PP85  antigen can be detected in lesional biopsies of pityriasis rosea.
43
 
 Other viruses like cytomegalovirus, EBV, adenovirus, influenza 
virus, parainfluenza virus, parvovirus B19, picornavirus have also been 
suspected to be associated with pityriasis rosea.
41
 Bacteria which are 
suspected to be associated with PR are  legionella, mycoplasma and 
chlamydia.  
 T lymphocytotoxic antibodies
44
 and antinuclear antibodies
45
  are 
also seen in patients with pityriasis rosea, which suggests an autoimmune 
etiology. 
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Clinical features: 
 The initial lesion of PR is known as primary plaque of PR or herald 
patch. Herald patch is seen in 50-90% of the inividuals with PR.
45
 The 
characteristic lesion of herald patch  is a 2-4 cm well demarcated oval or 
round salmon coloured, erythematous or hyperpigmented plaque with 
fine collarete of scale, just inside the periphery of the plaque. It is usually 
situated on the thigh or upper arm, the trunk or the neck; rarely it may be 
seen on the face, scalp or the penis. A gap of  2 days to 2 months may be 
there between herald patch and secondary eruption. But usually 
secondary eruption occurs within 2 weeks of  appearance of mother 
patch. 
 The secondary eruption can be of two types. i)  small plaques 
resembling miniature form of primary plaque distributed along the line of 
clevage in a Christmas tree  pattern. ii) small red non scaly papules that 
spreads peripherally. Secondary eruptions occurs in crops  at intervals of 
a few days to reach a maximum in about 10 days. The lesions are mainly 
distributed over anterior aspect of chest, abdomen, back. Sometimes the 
lesions may be seen over the neck and proximal extremities.  
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 In children, there will be predominantly papular or urticarial 
lesions in the early stages, which are later surmounted by an 
inconspicuous ring of fine scales.
46
  The centre of the lesion may be 
covered with scales in children which gives a lichenoid appearance .  
 An atypical presentation may be seen in about 20 percentage of the 
patients.
45
 The herald patch  may be absent or present as double or 
multiple lesions. The primary plaque may be the only manifestation of the 
disease. Papular PR is the most common atypical presentation in children. 
Vesicular, pustular,purpuric, haemorrhagic, erythema multiforme like  
and urticarial  like atypical morphological types may be seen. In children 
distribution of the secondary eruptions mayoccur exclusively over the 
extremities,and face. Localized forms of Pityriasis rosea may be seen 
over scalp , axillae, vulva and groin. 
 Severe pruritis  is seen in about 25 percentage of the patients. 
Usually children do not complain of  intense pruritis. Flu like symptoms 
like  generalised malaise, headache, nausea , loss  of appetite , fever and 
arthralgia are reported in a minority of patients. 
  
  
28 
 
DIAGNOSTIC CRITERIA OF PITYRIASIS ROSEA
47 
Essential clinical features: 
1. Discrete circular or oval lesions 
2. Scaling on most lesions 
3. Peripheral collarette scaling with central clearance on at least two 
lesions 
Optional clinical features (at least one has to be present): 
1. Truncal and proximal limb distribution, with less than 10% of 
lesions distal to midupper-arm and mid-thigh and secondary 
eruptions. 
2. Orientation of most lesions along direction of the ribs 
3. A herald patch (not necessarily the largest) appearing at least two 
days before the generalized eruption 
Exclusional clinical features: 
1. Multiple small vesicles at the center of two or more lesions 
2. Most lesions on palmar or plantar skin surfaces 
3. Clinical or serological evidence of secondary syphilis 
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Histopathology:
5 
 Epidermis will show mounds of parakeratosis with plasma, 
decreased granular layer, spongiosis,  moderate  acanthosis. Dermis will 
show perivascular infiltrate predominantly of   lymphocytes, eosinophils 
and histiocytes and extravastion of RBCs. Exocytosis is also seen. Herald 
patch will show pronounced acanthosis, deeper and denser perivascular 
inflammatory infiltrate and papillary dermal edema. 
Differential diagnosis:
45 
 Guttate psoriasis, tinea corporis , pityriasis versicolor , nummular 
dermatitis, parapsoriasis ,pityriasis lichenoides chronica, drug eruptions, 
viral rashes and secondary syphilis. 
Treatment : 
 No active treatment is necessary as pityriasis rosea have a self 
limiting course.
45
We should educate  the patient about the disease process 
and reassure them. If the child is symptomatic , topical antipruritics, 
topical steroid and oral anti histamines can be given. If the patient 
presents with flu like symptoms in the earlier stage or with  extensive 
disease , a high dose of acyclovir will hasten the resolution.
42
 
Phototherapy is also useful in some patients.
48
Earlier oral antibiotics like 
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erythromycin and azithromycin were thought to have beneficial role in 
PR.The use of oral erythromycin antibiotic (1 g four times a day for 2 
weeks for adults) was reported to clear the disease
49
 within 2weeks of 
treatment but later studies have proven that  there  is no significant 
efficacy for these antibiotics.
50,51
 
Prognosis:
45 
 All patients with  PR will have a spontaneous resolution of the 
disease  , normally between 4-10 weeks after the onset of the disease. 
Post inflammatory hypopigmentation and hyperpigmentation can be 
there.  Patients who are treated with phototherarpy have more chance of  
developing post inflammatory hyperpigmentation. 
LICHEN PLANUS 
 Lichen planus is a pruritic papulosquamous disease of unknown 
etiology which is characterised by violaceous flat topped polygonal scaly 
papules involving the flexor aspect of wrists, legs, oral and genital 
mucosa.
52
Lichen planus is derived from the greek word leichen meaning 
tree moss and latin word planus meaning flat.
53
 The word lichen planus is 
first coined by Erasmus Wilson in 1869.
54
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Epidemiology   
Lichen planus is distributed worldwide.  Overall prevalence of LP in 
general population is less than 1 percent .
55
 Lichen planus is more 
common in adults above the age of 30.About 60-65% of cases occur in 
adults above 30 years of age. Both oral LP and cutaneous LP are reported 
rarely in children. Various studies have shown a prevalence of 2-11% in 
children and adolescents.
55
 In a study conducted in children in 
Birmingham ,UK there was an over representation of south Asians in the 
series.
56
 The youngest age of LP was reported in a 3 weeks infant.
57
 
 Although LP is sporadic in origin, cases with familial 
predisposition are recorded. In the literature , less than 100 cases of 
familial lichen planus have been reported.
58
 
About 10-15% of adult patients with cutaneous LP will have  nail 
involvement.
59
In children nail involvement is rare. Nail involvement in 
children ranges from 0-16.6%.
55
 In a study conducted in nail LP in 
children, out of 15 cases, 10 children had typical nail matrix lesions, 2 
children had 20-nail dystrophy (trachyonychia), and 3 children had  
idiopathic atrophy of the nails.
60 
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Mucosal involvement is seen in upto 40% of the paediatric patients 
as compared to 50-70% of adult patients.
55,61.
 Oral lichen planus without 
cutaneous lesions will occurin 20-30% 0f patients.
58
In paediatric 
population,mucosal involvement is more common in children in India and 
Kuwait.
55
Follicular involvement of LP is rare in childhood.
 
Aetiopathogenesis  
 Various theories have been put forwarded to explain the etiology of 
LP  but exact mechanism has yet to be elucidated. 
 In 1977,Black proposed an autoimmune mechanism in the  
etiopathogenesis of LP. This is based on clinical and histological 
similarity of LP with LE, association of other autoimmune disease with 
LP and immunoglobulin staining of basement membranes and colloid 
bodies which is similar to autoimmune disease.
62 
 Specific HLA types have been found associated with LP. HLA A3, 
HLA A5, HLA Bw35and HLA DR1have been found  in close association 
with LP. HLA haplotypes reported in familial cases are  HLA B7, -Aw19 
,-B18 and –Cw8. HLA B8 is more strongly  associated with oral lichen 
planus and HLA Bw5 with cutaneous LP.
63 
The pathogenesis of LP can be explained in the following steps; 
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Antigen recognition:
55 
 The nature of the antigen which  stimulates  the pathogenetic 
process is unknown. The antigens may be a contact allergen, drug , viral 
or infectious agents or an unidentified immunogenic target. 
 The most import contact allergen proposed as an antigen is 
mercury in dental amalgam. Other metals which act as contact sensitiser 
are gold, palladium and beryllium. Viral etiologies in lichen planus are 
HSV2 , HIV, HCV and HPV. Bacterial infections like syphilis, 
helicobacter pylori are also suggested in the etiology of LP. 
Cytotoxic lymphocyte activation:
55 
 Antigen recognition will lead to activation,clonal expansion and  
proliferation of CD8
+
 T cells. As a result , cytokines and chemokines like  
interleukins , interferon gamma, TNF α and TGF β1 are secreted.  Both 
pro and anti inflamatory cytokines are secreted simultaneously. Clinical 
behaviour is determined by the balance between lymphocytic activation 
and downregulation. The lymphocytes interacts with basement membrane 
resulting  in apoptosis, basement membrane disruption  , reduplication 
and subepidermal clefting. 
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Keratinocyte apoptosis 
55
 
 The activated cytotoxic T cells will trigger apoptosis of the 
keratinocytes.  TNFα and granzyme B which are secreted by T cell will 
lead to keratinocyte apoptosis. Binding of CD95L to CD95 on 
keratinocyte will also trigger the process.Matrix metalloproteinase 
secreted by T cells will block the cell survival signals to keratinocyte and 
induces apoptosis, thus disrupting the epithelial basement membrane.  
CLINICAL FEATURES 
 Classical LP lesions appear as purple or violaceous flat topped 
polygonal papules which variesin size from  pin point to 1.5cm. The 
typical site of involvement in both adult and children are volar aspect of 
wrists, around ankles and lumbar region,often bilateral and  
symmetrical.Koebnerisation may be positive in lichen planus.In a report 
of fifty cases of lichen planus 28% of the children showed koebner 
phenomenon.
64
Wickhams striae may be evident over the papules or 
plaques which appear as white reticular network.LP lesions are generally 
mildly to intensly pruritic,but in children the lesions are often non 
pruritic. Hypertrophic  lesions will have severe itching. 
 Childhood onset LP will be similar in presentation to classical LP, 
with lesions typically affecting lowerlimbs. The course of LP in children 
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is similar to the adult course with majority of disease resolving within 1 
year.
 65
 
 Variants of LP are hypertrophic,follicular, actinic, linear, LP 
pigmentosus, annular,atrophic,LP of palms and soles. Mucosal,nail and 
scalp involvement can be seen in LP. 
 Linear LP is more common in childhood.
65
It may present as a few 
papules arranged linearly in a few centimetres or can extend to involve a 
whole limb. Multiple linear LP lesions following Blaschko lines  has been 
reported in some individuals. Multiple linear LP was documented in a 
patient with human immunodeficiency virus (HIV) 
infection.Hypertrophic LP  is a chronic variant of LP which presents as 
intensely pruritic thick verrucous hyperkeratotic plaques which are 
distributed bilaterally symmetrical over the shins.This variant is 
frequently reported in children.
65
 
 Annular LP is an uncommon clinical variant of LP which is 
characterized by a ring like cluster of purple and polygonal flat topped 
papules with a central normal or atrophic skin. Actinic LP  presents as 
annular or discoid patches with deeply pigmented centre  and peripheral 
halo of hypopigmentation. Actinic LP generally occurs in children or 
young adults in tropical countries.  
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 Follicular LP is rare in childhood.
65
Clinically it presents as 
perifollicular scaling,erythema,hyperkeratotic papules and loss of 
follicular orifices. Most common site of involvement on the scalp is 
parietal and vertex areas.  
 Lichen planus pemphigoides is a rare autoimmune blistering 
disease in which typical lichen planus lesions evolve into bullous lesions 
with a mean lag time of 8 weeks. The most common site involved 
areextremities and about half of the affected children will have 
palmoplantar lesions. 
 Nail involvement in children is relatively rare as compared to 
adults. Finger nails are involved more than that of toe nails.The  nail 
changes include exaggeration of the longitudinal lines ,linear depressions, 
loss of lustre,thinning of nail plate,splitting or nicking of nail margin, 
atrophy,pterygium,onycholysis , subungual hyperkeratosis. Violaceous 
lines or papules in the nail bed may occasionally seen through the nail 
plate.LP has been shown to cause  idiopathic atrophy of nails in 
children.Rarely Lp can cause severe ulceration of soles which can lead to 
complete loss of toe nails.
66 
 Mucosal involvement in LP in children is less common than adults. 
Most common sites involvedare the buccal mucosa and tongue. Mucous 
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membrane of genitalia,anus and larynx can also be involved. Rare cases 
of tympanic membrane and oesophagus involvement have also been 
reported
67
. The morphological type of mucosal LP are reticular, erosive, 
atrophic,bullous and  plaque type. Reticular patches and white plaques on 
the buccal and gingival mucosa and violaceous papules over the lips are 
the most common types described. Ulcerated variant is very rare in 
children. 
Histopathology: 
5 
 The papules or plaques of lichen planus will show compact 
orthokeratosis,wedge shaped hypergranulosis,irregular acanthosis giving 
a saw toothed  appearance of rete ridges,vacoular alteration of basal layer 
and band like dermal lymphocytic infiltrate close to the epidermis. Lower 
epidermis will show necrotic keratinocytes, which are also called as 
colloid orhyaline or cytoid or civatte bodies. They will have a 
homogenous eosinophilic appearance measuring an average of 20um in 
diameter.The dermal infiltrate is composed almost entirely of 
lymphocytes intermingled with macrophages. A few eosinophils or 
plasma cells may be there. As a result of damage to basal cells, the dermis 
will show pigmentary incontinence and melanophages. An artifactual 
separation of epidermis and dermis termed Max joseph space is seen 
occasionally. 
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Differential diagnosis
58,68 
Table 2: Differential diagnosis of lichenplanus in children 
Type of lichen planus  Differential diagnosis 
Classical lichen planus  Psoriasis 
Lichen simplex chronicus 
Drug eruption 
HypertrophicLichen Planus Lichen simplex chronicus 
Prurigo nodularis 
Lichen amyloidosis 
Lichenoid psoriasis 
Follicular 
 
 
Darier’s Disease 
Keratosis pilaris 
Lichen scrofulosorum 
Lichen nitidus 
 Linear Lichen Striatus 
Linear psoriasis 
Inflammatory linear verrucous 
epidermal nevus 
Actinic  
 
 
Annular psoriasis 
Granuloma annulare 
Tinea corporis 
 Atrophic  Lichen sclerosus et atrophicus 
 Guttate  Guttate psoriasis 
 Lichen planus of oral 
mucosa 
 
Candidiasis 
Leukoplakia 
Contact dermatitis to dental amalgam 
Healing oral erosions of Pemphigus 
vulgaris 
 Lichen planus of palms and 
soles 
Psoriasis 
Focal palmoplantar keratoderma 
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Treatment  
 Idiopathic LP oftenhas  a self resolving  natural course. Some 
patients will have  remission and exacerbation of the disease. 
 In paediatric population ,first line of therapy in cutaneous or oral 
LP is potent and super potent topical steroids with or without 
antihistamines. Topical steroids will help in reducing pruritis and flatten 
skin lesions. Topical steroids have to be continued for several weeks to 
achieve these effects.But there is  risk of atrophy in long term use. 
 Topical calcineurin inhibitors such as tacrolimus and pimecrolimus 
can be tried in those who require prolonged therapy.
68 
 In oral LP, avoidance of triggers and maintenance of good oral 
hygiene should be observed. Topical steroids in an adhesive base is 
needed for oral LP for prolonged period. Other treatment options for oral 
LP in children are topical tretinoin ,  isotretinoin, tacrolimus and 
pimecrolimus.
68 
 Oral corticosteroids should be considered in severe generalised LP 
of childrenor if topical treatment fails to relieve the symptoms. Oral 
corticosteroids should be given in a dose of 0.5-1mg/kg for 2-6 weeks 
with gradual tapering thereafter. Other treatment options in children are 
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dapsone ,griseofulvin, metronidazole,oral retinoids,cyclosporine and 
thalidomide. NBUVB and PUVA therapy is also used in generalise LP. 
PROGNOSIS
58,67 
 Skin lesions in LP will most often subside within 9-18 months. 
Occasionally lichen planus may persist for years. About 10-20% of 
patients sufferfrom  one or more recurrences of their skin lesions. 
Hypertrophic LP and oral LP will take long time to resolve. The lesion 
may tend to flatten or resolvewith hyperpigmentation, which may persist 
for months or years. 
 LP lesions may recur in about 15-20% of the patients. Recurrences 
are more common in generalised LP.  Malignant transformation is seen in 
less than 1 percent of persistent oral mucous lesions on long term follow 
up. 
PITYRIASIS RUBRA PILARIS 
 Pityriasis rubra pilaris (PRP) was first described in 1856 by 
Devergie and was named by Besnier in 1889.
69
 Pityriasis rubra pilaris 
(PRP) is a group of keratinisation  disorders that have in common, 
circumscribed follicular keratoses, branny scale and an orange-red 
erythema surrounded by normal skin, and palmoplantar keratoderma .
70
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Epidemiology 
 In India  , incidence of PRP is 1 in 50,000 as compared to 1 in 
5000 in  Great Britain ,which makes clear that there is a racial 
variation.
71,72
 There is a bimodal age of onset without sex predilection. 
The most common type of   PRP is adult onset classical type. 
Aetiopathogenesis:  
 The aetiology and pathogenesis of PRP are still poorly understood. 
It represents a disorder of keratinisation. Most childhood cases of PRP are 
acquired without any family history,but an  autosomaldominant 
inheritance is also reported.
73
 Clinically and histologically, acquired and 
hereditary forms are indistinguishable, but autosomal dominant form will 
have less severe onset from birth to early childhood.  
 Vitamin A deficiency, infection and trauma are the various 
postulated causes of PRP. 
74,75,76
Studies have shown that there is an 
association between PRP and decreased retinol binding protein. A  study 
conducted on PRP in children  by Allison  D S et al showed that  27% of  
patients had preceeding upper respiratory tract infection and 10% had 
preceeding trauma.
76
 Epidermal thymidine labelling is increased from an 
average normal 3% to 27%. 
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 PRP may be a result of dysregulation of immune system and 
abnormal response to various antigenic  triggers .
77
 Bacterial or viral 
infection beforethe eruption are commonly noticed in juvenile PRP. PRP 
is also associated with rheumatism and malignancy.
78
 Photoaggravation is 
also a suggested triggering factor.
79 
 
Down’s syndrome, osteoporosis,arthropathy , coeliac sprue, protein 
losing enteropathy,hypothyroidism,hyperparathyroidism and myasthenia 
gravis are rare associations of PRP.
80 
Griffiths classification:
71 
Based on clinical and morphological appearance,Griffiths  proposed a 
classification of five types  
Type 1: Adult onset, classical 
Type II: Adult onset, atypical 
Type III: Juvenile onset,  classical 
Type IV: juvenile onset,circumscribed 
Type V: Juvenile onset,  atypical 
Juvenile onset PRP is discussed in detail 
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Type III (Juvenile onset, classical)
70 
 
 The age of presentation of type III PRP is 5-18 years. Type III PRP 
accounts about 10% of the total PRP cases. Type III resembles type 1 
PRP clinically, but type III have a better prognosis than type 1.It starts as 
orange red macule on head, neck or upper trunk with fine scales which 
later spread cephalocaudally to involve whole body. Later, perifollicular 
erythematous papules with central acuminate keratinous plug develops. A 
characteristic feature of widespread PRP is “islands of sparing”. Palms 
and soles will show thick yellow keratoderma which is referred to as 
“PRP sandal”. Scalp may be covered with pityriasiform scales. Ectropion 
may be seen. Nails may be normal or yellow,thickened and curved. 
 Pruritis  may be seen in the erupting stage. Sometimes burning 
sensation will be there. The symptoms will improve as the disease 
stabilises.Rarely type III can get transformed to typeIV. 
Type IV: Juvenile onset, circumscribed
70 
 The age of onset of type IV PRP is usually less than 12years.It 
presents as  asymptomatic,erythematous grouped follicular papules over 
extensor aspect of knees and elbows. A few erythematous scaly macules 
or follicular keratotic plugs can be seen in the trunk.  Marked 
Palmoplantar keratoderma can be seen in some cases.the lesions are 
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nonpruritic. Scalp is spared in this type. These lesions does not progress 
to type I and type III. 
Type V :  Juvenile onset ,atypical
70 
 This type usually present since birth or in the first few years of life. 
It is characterised by follicular hyperkeratosis with only minimal 
erythema. Scleroderma like changes of the digits have also been reported 
in many patients. This type usually persists throughout  life.Majority of 
familial PRP cases are of type V . It presents as follicular ichthyoses and 
erythrokeratoderma.
 
HIV associated 
 PRP like eruptions have been documented in all age groups with 
HIV infection. it is usually diagnosed in known HIV patients. But 
sometimes the eruption can be a sign of HIV infection. 
 This type is associated with acne conglobata , cystic acne or 
hidradenitis suppurativa. It is usually refractory to therapy but early 
intiation of  HAART may be effective.
81 
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Histopathology
5 
 A fully developed lesion shows alternating orthokeratosis and 
parakeratosis oriented in both vertical and horizontal directions,slight 
spongiosis,focal or confluent hypergranulosis,acanthosis with broad and 
short rete ridges,thick suprapapillary plates in the epidermis. Dermis will 
how mildly dilated vessels and superficial perivascular lymphocytic 
infiltrate. 
Differential diagnosis
81 
 Psoriasis, lamellarichthyosis , keratosis pilaris, erythrokeratoderma  
variabilis 
Treatment  
 Mainstay of treatment for PRP is topical treatment.General 
measures like use of gentle bathing soap,liberal use of emollients should 
be advised. Topical steroids, keratolytics, calcipotriene and retinoids are 
commonly used. 
 Oral retinoids like acitretin(0.5-1mg/kg) and isotretinoin (0.75-
1.5mg/kg) can be used in severe disabling disease.Methotrexate and 
cyclosporine alsohave been reported to be effective.
80 
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Prognosis  
 Type III PRP often resolves with in an average period of 1-2 years. 
Couse of type IV PRP is uncertain, but some cases clear in the late teens. 
Type V PRP have a chronic course. It usually resolves with retinoids but 
relapses on stopping the drug.
81 
LICHEN STRIATUS  
 Lichen striatus is a self limiting disease of unknown origin 
characterized by inflammatory  papular eruptions in a  linear distribution 
or Blaschkoid  distribution. 
82 
Epidemiology 
 It is more common in children between the age of 5-15years,with a 
female preponderance. 
83
About two third of the cases will have lesions 
over the limbs. Pruritis is moderate and occurs in about 10% of the cases. 
Aetiology 
 Definitive aetiology of lichen striatus is unknown. Lichen striatus 
is an acquired disease. Trauma, ultraviolet light and contact dermatitis 
have been implicated. Seasonal  variation was reported in an Australian 
study, and was found to be more frequent in the spring season.
84
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          Studies on lichen striatus of children  have shown a high 
association with atopic dermatitis.Various studies have shown that 60-
80%of children with lichen striatus have a history of atopy.
85
The 
abnormal immune status associated with atopy may contribute to the 
development of lichen striatus. 
           Viral infection has also been  suggested as a trigerring factor. 
Lichen striatus have shown an increased amount of IL-1β,whichsupports 
an in situ inflammation  driven process,trigerred  by infectious 
pathogens.
86 
 An epigenetic mechanism has been suggested in the occurrence of 
familial cases of lichen striatus.  Eventhough familial cases are rare, cases 
of simultaneous occurrence  in siblings  was reported . This also suggests 
a  common environmental trigger.
87
 
 Congenital presence of an abnormal skin clone due to a postzygotic 
mutation has also been proposed  as a possible explanation for LS .
88
 The 
cells bearing the mutation will be quiescent. A trigger, most commonly a 
viral infection will cause this aberrant clone to express a novel antigen, 
resulting in the  disease manifestations.. 
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Clinical features 
 Lichen striatus initially  presents as asymptomatic, discrete tiny 
erythematous and lichenoid  papules which later coalesce to form a 
irregular linear band. The surface of the papules may have an associated 
scaling. Common sites involved are extremities and trunk. It usually 
presents as a unilateral single lesion,although rare cases of multiple and  
bilateral involvement are reported.
89. 
Facial involvement is also seen. 
 
The lesion progress for 2to 3weeks and resolves within a period of 
3-12 monthsleaving a postinflammatory hypopigmentation or 
hyperpigmentation.
 
 Nail involvement can be seen, frequently on the fingers,  especially 
the thumb. Longitudinal ridging, splitting and thinning with 
onychodystrophy are common nail manifestations . Nail lichen striatus 
may preceed the onset of cutaneous lesions.
90 
Histopathology
5 
 Epidermal changes include focal parakeratosis, spongiosis, 
intracellular edema often associated with exocytosis. Dermis will show 
superficial perivascular inflammatory infiltrate of lymphocytes  with 
histiocytes. Focally in the papillary dermis the infiltrate may have a band 
like distribution with extension into the the lower portion of epidermis. 
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The corresponding regions of epidermis will show vacuolar alteration of 
the basal layer and necrotic keratinocytes with melanophages in the 
papillary dermis. 
Differential diagnosis
91 
 Linear psoriasis, linear Darier's disease, linear lichen planus,linear 
porokeratosis and other linear nevi, are to be considered in the differential 
diagnosis. ILVEN is the most important differential diagnosis  for lichen 
striatus,but it will have an earlier onset and will persist indefinitely. 
 Hypomelanosis of Ito and vitiligo are the differential  diagnosis in 
the hypopigmented stage. 
Treatment 
 Benign and self limiting nature of the disease should be explained 
to the parents. Intralesional steroid can be used in persistent case. If nails 
are affected, potent topical steroids can be used. Topical tacrolimus 
ointment will hasten the resolution of lesion. 
Prognosis  
 Lichen striatus is a benign condition. The mean duration of the 
lesion is 6-9 months. Relapses can occur within 4 years. The lesions may 
heal with post inflammatory hypopigmentation.
91
. Nail matrix lichen 
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striatus will not cause permanent damage and will resolve 
spontaneously.
92 
SEBORRHEIC DERMATITIS  
 Seborrhoeic dermatitis is a common chronic papulosquamous 
dermatosis,which is characterised by self limiting erythematous scaly 
eruptions that occurs primarly over the face,  postauricular, presternal and 
intertrigenous areas. The term seborrheic dermatitis was first coined by 
Unna in 1887.
93 
Epidemiology  
 The exact incidence of seborrheic dermatitis is unknown, but the 
disorder is quite common. Seborrheic dermatitis showed an incidence of 
1.6% among children , in a study conducted in India
94
. In United States it 
affects about 3-5% of general population.
95
 Seborrheic dermatitis have 
bimodal peak, one in infancy and second around fourth to seventh 
decade. Males are affected more frequently than females. Seborrheic 
dermatitis is found in upto 85% of patients with HIV infection. 
Aetiopathogenesis 
 The aetiology of seborrheic dermatitis is not well understood. 
However many factors are implicated in the pathogenesis of seborrheic 
dermatitis. 
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 A positive correlation with sebum and sebaceous have been 
postulated. It is evidenced by predilection for areas of high sebaceous 
density and correlation of activity with increased hormonal levels during 
first year of life and adolescents. 
 Theories have suggested that Malassezia furfur plays an important 
role in the etiology of seborrheic dermatitis. Ruiz maldonao et al detected 
Malassezia furfur in 73% of patients with seborrheic dermatitis.
96 
 Studies done in infantile seborrheic dermatitis have demonstrated 
abnormality with regard to essential fatty acids.  A transient impairment 
in delta-6-desaturase was detected in these children.
96 
 Although a family history of seborrhea is quite often reported , 
there is no conclusive evidence that heredity plays a role. 
 Seborrheic dermatitis is associated with parkinsonism and 
neurological disorders where sebum production is increased. It is also 
associated with some medical conditions like malabsorbtion, epilepsy, 
obesity , alcoholic pancreatitis.
97,98
 Seborrheic dermatitis is an established 
marker of HIV infection and also seen in local cutaneous 
immunosuppression.
99 
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Clinical features  
 The various clinical patterns of seborrheic dermatitis are shown in 
Table 3. 
Table 3. CLINICAL PATTERNS OF SEBORRHEIC 
DERMATITIS
100
 
INFANTILE SCALP (CRADLE CAP) 
TRUNK  
LEINER’S DISEASE 
• .Non-familial 
• Familial C5 dysfunction 
ADULT SCALP 
• Dandruff 
• Inflammatory 
FACE 
TRUNK 
• Petaloid 
• Pityriasiform 
• Flexural 
• Eczematous plaques 
• Follicular 
GENERALISED  
 Infantile seborrheic dermatitis appears between second and third 
week of life and peak incidence at the age of 3 months. Infantile 
seborrheic dermatitis in scalp manifests as cradle cap, i.e. yellowish or 
  
53 
 
whitish greasy thick adherent , frequently confluent scales occurring 
mostly over vertex or frontal regions. Pruritis is usually absent or may be 
mild. 
 On the face ,it appear as small round scaly erythematous areas 
mainly over forehead,eyebrows, retroauricular region and nasolabial 
folds. The lesions may also develop over neck, axillae,umbilicus,inguinal 
and intergluteal folds. In the intertriginous areas the lesions will become 
macerated and eroded. So scaling will be prominent only at the 
peripheries. These areas may have secondary candidal or bacterial 
infection evidenced by erythematous papules or pustule.Blepharitis is 
also a common manifestation of seborrheic dermatitis in infants.
100 
 Occasionally, seborrhoeic dermatitis may become generalized, 
resulting in erythroderma in infants.Leiners disease is a severe type of 
seborrheic dermatitis which is associated with diarrhoea, failure to thrive 
and erythroderma.A possibility of immunodeficiency should be suspected 
when it is severe, generalised and exfoliative,in adults.  
Histopathology: 
101 
 The histopathological features of seborrheic dermatitis vary 
according to different clinical stages. 
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 In acute and chronic stage, there will be orthokeratosis, 
parakeratosis follicular plugging, spongiosis, psoriasiform hyperplasia. 
Dermis will show superficial perivascular infiltrate of histiocytes and 
lymphocytes.In chronic stage superficial plexus of dermis will show 
markedly dilated capillaries and venules, 
Differential diagnosis
 
 Atopic dermatitis, psoriasis, intertrigo, Langerhans’cell 
histiocytosis, multiple carboxylase deficiency,zinc deficiency and tinea 
capitis. 
Treatment  
 Infantile seborrheic dermatitis can be best managed by frequent 
shampooing , with a gentle ‘no tears’ shampoo.Thick adherent scale can 
be removed by application of baby oil or mineral oil followed by gentle 
scraping with a toothbrush and shampooing.If there is severe 
inflammation, a low potent topical steroid .For non scalp areas a low 
potent topical steroid or antifungal will be usually effective.Topical anti 
bacterial and candicidal will be useful if superadded infection is there 
 Blepharitis can be managed by warm compressess, non irritating 
shampoo or  mechanical removal of scales when necessary. 
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Prognosis  
 Infantile seborrheic dermatitis has an excellent prognosis. The 
lesions will clear within 3-4 weeks in some patients.  Most of the patients 
will have spontaneous clearance of the lesion by the age of 8-12 months 
LICHEN NITIDUS 
 Lichen nitidus was first described by Pinkus in 1907.
103
In Latin, 
the word nitidus means “shiny” or “glistening”.  Lichen nitidus is a self 
limiting chronic inflammatory papulosquamous disorder defined more 
often in children and young adults. 
Epidemiology 
 Epidemiological data of lichen nitidus is not well documented. 
Lichen nitidus occurs more common in blacks than Caucasians. Children  
andyoung adults are affected more than that of elderly. Lichen nitidus is 
more common in males than females. A 25 year survey  of  skin disease 
in African-Americans reported an incidence of  3.4 cases/10,000 
population for lichen nitidus..
104
 
Aetiopathogenesis  
 The exact aetiology of lichen nitidus is unknown.  LN is sporadic 
in origin but familial cases have been reported. In the earlier days it was 
thought to be a tuberculoid reaction. Lichen nitidus was once thought to 
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be a variant of lichen planus , as the two diseases  coexisted in the same 
individual and also due to the development of lichen planus following 
generalised lichen nitidus. 
 Recently postulated mechanism for the pathogenesis of lichen 
nitidus is that  an allergen may intiate the pathological process. Allergen 
will cause epidermal and dermal antigen presenting cells  to activate cell 
mediated response , initiates accumulation of  lymphocytes and form 
discrete inflammatory  papules.
103 
Clinical features 
 The lesions of lichen nitidus are characterised by multiple grouped 
and discrete pinpoint to pinhead sized ,fleshcoloured to slight pink 
flat,shiny papules,commonly distributed over forearm, penis, chest and 
abdomen. The papules will be hypopigmented in blacks. Scaling may be 
minimal and can be elicited by rubbing the surface of the papules. 
Koebnerisation and linear arrangement can be seen.  
 Rare forms of lichen nitidus are generalised,linear,actinic, 
vesicular, hemorrhagic, perforating, purpuric and spinous follicular. 
Lichen nitidus may rarely affect mucous membrane,palms,soles and nails. 
In children rare variants like generalised lichen nitidus, perforating type 
and actinic lichen nitidus  are reported. 
103 
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 Atopic dermatitis , Down’s syndrome  and juvenile chronic 
arthritis have been reported to be associated with lichen nitidus in 
children.
105,106,107
 In adults, lichen nitidus are reported to be associated 
with  Crohn’s disease, erythema nodosum and MEN2e. 
Histopathology
5 
 Epidermis will be flattened wth focal parakeratosis, diminished 
granular layer, vacoular alteration of  basal layer and focal subepidermal 
clefting. .  Colloid bodies are seen rarely. Dermis will show a well 
circumscribed mixed cell granulomatous infiltrate  . At each lateral 
margin of the infiltrate rete ridges tend to bend  inward  and seem to 
clutch the infiltrate in a manner  of a “ claw clutching a ball”. The 
infiltrate is composed of  lymphocytes,monocytes and  a few 
multinucleated epitheloid histiocytes. Transepidermal elimination of the 
infiltrate through the thinned epidermis can occur. Capillary wall 
degeneration and extravasation of RBCs are seen in purpuric and 
hemorrhagic lesions.  
Differential diagnosis
65 
 Lichen planus, plane wart, keratosis pilaris ,Darier’s disease,  
lichen spinulosus, lichen scrofulosorum, id reaction are considered as 
differential diagnosis. 
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Prognosis 
 LNis a chronic self limiting disease with an average duration of 1 
year. New lesions may continue to develop as older lesions resolve. 
Lesions heal without scar formation or pigmentary abnormalities. The 
eruption may persist rarely. 
Treatment  
 Medical treatment is considered when the patient is symptomatic or 
when the lesions are generalised and persistent. Topical treatment 
includes mid to high potent steroids and tacrolimus. Immunotherapy with 
dinitrochlorobenzene has been used. Studies have shown that oral 
isotretinoin is effective in generalised LN and acitretin in palmoplantar  
involvement. 
 In refractory cases NBUVB, PUVA, astemizole, enoxaparin and 
etretinate have been used. Systemic retinoids can cause premature 
epiphyseal plate closure and stop normal growth in children. 
PARAPSORIASIS  
 The term parapsoriasis was coined by Brocq in 1902 to encompass 
a group of conditions that clinically resembled psoriasis and seborrhoeic 
dermatitis.
108
 Parapsoriasis is classified into large plaque parapsoriasis 
and small plaque psoriasis.  
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Epidemiology  
 Parapsoriasis is a disease predominantly seen in adults. Males are 
affected more commonly than females. Small plaque psoriasis shows a 
definite male predominance of   approximately     3-4: 1.
109
 Parapsoriasis 
is rarely seen in children. In a study, about 5% of small plaque psoriasis 
and 20% of large plaque psoriasis were reported in children. 
CLINICAL FEATURES
65,108 
Small plaque parapsoriasis 
 Chronic superficial scaly dermatitis, persistent superficial 
dermatitis digitate dermatosis and xanthoerythroderma perstans are the 
synonyms for small plaque parapsoriasis. 
 The lesions are usually insidious in onset and asymptomatic. Most 
common sites involved are trunk and limbs. The typical lesions are 
hyperpigmented or yellowish red,round or oval, patches with well defined 
sharp borders of size 1-5cm. The patches will be covered with fine 
moderately adherent scales.  In the digitate variant of small plaque 
parapsoriasis elongated fingerprint like lesions oriented along the 
cleavage lines are seen commonly over the flanks. In this type the long 
axis of the lesions will be more than 5 cm. A variant of parapsoriasis, 
known as xanthodermia perstants will have a yellowish hue . 
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Large plaque parapsoriasis 
 Parakeratosis variegate,retiform parapsoriasis,atrophic 
parapsoriasis and poikilodermatous parapsoriasis are the synonyms for 
large plaque parapsoriasis. 
 Large plaque psoriasis commonly occurs in middle aged males 
with a peak incidence in fifth decade. Unexposed areas, especially trunk  
and flexures are the most commonly affected areas. Extremities and 
breasts in females are other common sites. The lesions will present as 
persistent ,reddish brown or salmon pink patches or plaques with small 
and scanty scaling which are more than 5cm,  often  measuring more than 
10cm. The lesion  are stable in size but will increase in number. Later 
atrophic changes along with mottled pigmentation and telangiectasia   can 
occur over patches and plaques. The surface will have wrinkling – 
“cigarette paper wrinkling.”  
 A rare variant , known as retiform parapsoriasis which refers to a 
net-like or zebra-like pattern of scaly macules and papules that eventually 
becomes poikilodermatous in appearance. An icthyosiform variant of 
large plaque parapsoriasis is also reported in the literature. 
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Histopathology
5
 
 Elongated mounds of parakeratosis with collection of plasma 
above a basket weave cornified layer is a characteristic finding. 
Epidermis will also show acanthosis,spongiosis and exocytosis of 
lymphocytes. Papillary dermis will show mild superficial perivascular 
lymphocytic infiltrate.  
 Early stages of large plaque parapsoriasis will show similar 
features as that of  small plaque parapsoriasis. Advanced lesions will have 
epidermal atrophy , marked exocytosis of lymphocytes, and a band-like 
infiltrate of lymphocytes in the papillary dermis. Dilated vessels and 
melanophages can be seen in dermis. 
Differentialdiagnosis
10,110 
 Small plaque parapsoriasis should be differentiated from nummular 
eczema, psoriasis vulgaris and guttate psoriasis,  pityriasis rosea, 
pityriasis lichenoides chronica and secondary syphilis 
 Large plaque psoriasis should be differentiated from plaque type 
psoriasis, tinea corporis, contact dermatitis, poikilodermatous skin 
conditions such as: Rothmund-Thomson syndrome, Bloom’s syndrome, 
dyskeratosis congenita, systemic lupus erythematosus, dermatomyositis, 
radiodermatitis ,patch stage of  mycosis fungoides. 
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Treatment  
 Patients with small plaque parapsoriasis should be reassured about 
the benign nature of the disease. Small plaque parapsoriasis can be treated 
with emollients, topical corticosteroids , topical tar products, and narrow 
band UVB therapy. Treatment response is variable and temporary. 
 LPP requires aggressive treatment. The goal of treatment is to 
suppress the disorder to prevent possible progression to overt MF. In 
large plaque parapsoriasis topical corticosteroids should be used with 
caution because of atrophic nature of plaques.Emollients ,NBUVB and  
PUVA therapy can be used.  
 Repeated  examinationwith sequential biopsies of suspicious lesion 
is needed every 3 months initially and then every 6 months to 1 year  for 
evidence of progression.
110
 If the histopathological  section shows  early 
stages of early MF , it can be treated with topical nitrogen mustard, 
bexarotene gel, imiquimod or carmustine. Narrow band UVB and broad 
band UVB therapy can also be used in such situations. 
Prognosis  
 Small plaque parapsoriasis  may persist for years to decades, 
without treatment. Malignant transformation is rarely reported. Various 
studies have shown that about 10-35% of large plaque parapsoriasis can 
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turn to mycosis fungoides. Retiform variant may  progress to overt MF in 
virtually all cases.
110
 So children with large plaque parapsoriasis should 
undergo serial biopsies to rule out malignant transformation. 
PITYRIASIS LICHENOIDES  
 Pityriasis lichenoides is a spectrum of cutaneous eruption of 
unknown etiology that mainly affects children and young adult. 
Jadassohn and Neisser first described pityriasis lichenoides in 1894 in 
two separate reports.
111,112
 Juliusberg in 1899 described the chronic form 
in 1899 and gave the name PLC.  Mucha in 1916 and Haberman in 1925 
described the acute form of pityriasis lichenoides and  Degos in 1966 
reported a severe febrile ulceronecrotic subtype now usually called febrile 
ulceronecrotic  Mucha Habermann disease (FUMHD) 
 Gelmetti et al.
113
 suggested an alternative classification. Based on 
anatomic distribution, they described three patterns: a diffuse form 
involving glabrous skin over the whole body surface, a central variety 
involving the neck, trunk, and proximal extremities, and a peripheral 
form with an acral distribution. Acral involvement including the face is 
more common in children. 
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Epidemiology  
 The prevalence and incidence of pityriasis lichenoies is not well 
documented.There is a male predominace of 1.5:1to 3:1.
110
A case of 
pityriasis lichenoides has been described at birth. PLC is seen in about 
37.5% of paediatric patients with pityriasis lichenoides. PLC is three 
times more common than PLEVA. About 50% of reported cases of  
febrile ulceronecrotic  Mucha Habermann disease have been seen in 
children. 
Aetiopathogenesis 
 Pityriasis lichenoides is a disorder of unknown etiology. Infectious 
agents such as Toxoplasma gondii, Epstein-Barr virus, 
cytomegalovirus,parvovirus B19 and HIV have been associated with 
some cases.
114 
Certain studies have demonstrated T cell clonality in 
pityriasis lichenoides ,which suggests that it is a benign lympho 
proliferative disease in which a vigorous host immune response prevents 
the condition from evolving into lymphoma. 
 Pityriasis lichenoidess is removed from parapsoriasis group of 
disorders and now considered  as a lymphocytic vasculitis.
115,116 
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 Epidermis of piryriasis lichenoides lesions have shown a reduction 
in CDla+ antigen-presenting dendritic (Langerhans) cells in 
immunohistologic studies. CD8+ cells predominate PLEVA lesions and 
PLC lesions will have both CD8+ and CD4+ cells. Majority of these 
Tcells will express cytolytic enzymes(granzyme band TIA-1)and  
memory proteins(CD45RO) . Presence of IgM, C3 deposition in the 
dermoepidermal junction and in the dermal vessel walls in the early acute 
lesions suggest a humoral response. These data suggest that PL may be 
due to persistent antigen stimulation triggered by an infectious agent  
resulting in immune complex formation.
113 
Clinical features 
PLEVA 
 PLEVA is characterised by acute onset of firm reddish papules of  
2-10mm size. Later the papules will become hemorrhagic, vesicular, 
necrotic and crusted,leaving scars with hyperpigmentation or 
hypopigmentation. The eruption may  sometimes be  associated with 
fever, headache, malaise and lymphadenopathy. Most common sites 
affected are anterior aspect of trunk, flexors, and proximal part of 
extremities. Lesions are usually non pruritic. The disease usually lasts for 
several weeks to months. After an acute course ,PLEVA can progress to 
PLC.   
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PLC 
 PLC may begin de novo or may evolve from PLEVA. It is 
characterised by recurrent crops of  lichenoid, reddish brown papules 
which are covered by mica like scales. The papules will involute within 
3-6 weeks leaving hyperpigmented macules which gradually fades. The 
lesions may last from several months to several years with frequent 
remissions and exacerbations. 
 In febrile ulceronecrotic Mucha Haberman disease, there will be 
acute onset of fever with purpuric papules and nodules. Later  multiple 
lesions  will coalesce to form diffuse large necrotic ulcers. 
Histopathology
5
 
 In PL, epidermis will show confluent parakeratosis, mild 
spongiosis, necrotic keratinocytes and basal cell vacoulation.PLEVA will 
have more pronounced vacoular degeneration with marked 
exocytosis.Dermis will have perivascular lymphocytic infiltrate which is 
more deep in PLEVA. Papillary dermis will show melanophages and 
extravasated RBCs. 
Differential diagnosis.
110 
 PLC: guttate psoriasis,pityriasis rosea,lichen planus and secondary 
syphilis. 
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PLEVA:Arthropod bites, Lymphomatooid papulosis, vasculitis, varicella 
FUMHD:Varicella,Lymphomatoid papulosis,Lymphoma 
Treatment  
 Ultraviolet therapy is the most effective therapy for pityriasis 
lichenoides. Satisfactory outcome is seen with oral antibiotics, 
particularly azithromycin and erythromycin. Topical corticosteroids and 
oral antihistamine have a role in reducing the associated pruritis. In 
persistent cases and ulceronecrotic variants,methotrexate and 
cyclosporine can be used. 
Prognosis and complications 
 Pityriasis lichenoides have variable outcome. It may recover 
spontaneously within weeks or may persist and recur for years. The 
duration of the disease in children correlate better with the clinical 
distribution of lesions. The longest duration will be seen in peripheral 
distribution and shortest with diffuse pattern.
117
 PLC will persist longer 
than PLEVA. Malignant transformation is very rare although case of PLC 
transforming to Tcell lymphoma has been reported. 
 Most common complication of  pityriasis lichenoides  is secondary 
infection. In febrile ulceronecrotic  variant the patient may develop 
arthralgia , gastrointestinal and central nervous system manifestations.  
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LYMPHOMATOID PAPULOSIS 
 Lymphomatoid papulosis was first described by Macauly in 
1968
118
. It is a benign recurrent self healing dermatosis with histologic 
features suggestive of lymphoma. 
Epidemiology  
 It is a rare disease with an incidence of about 1.2-1.9 per 1,000,000 
in adults.
119
 Boys affected with lymphomatoid papulosis have a younger 
age of onset than girls. The course of lymphomatoid papulosis issimilar in 
children and adults, including the risk of lymphoid malignancies. But 
some studies have shown that the disease in children will resolve more 
spontaneously than in adults.  
Clinical features  
 The lesions typically involve trunk and extremities. There will be 
recurrent crops of numerous reddish brown papules or vesiculopustules 
over a period of months to several years. The lesions will 
characteristically develop central hemorrhagic necrosis and crusting 
which gradually resolves with hyperpigmentation or hypopigmentation. 
Occasionally varioliform scars may develop. Rarely large ulcerating 
nodules, plaques or nonulcerating papules occur. Regional distribution 
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has been described in children although more generalised spread develops 
later. 
Histopathology
120,121
 
 There are three histological types described in lymphomatoid 
papulosis. 
 Type A (histiocytic type): This consist of scattered or grouped 
pleomorphic or anaplastic lymphoid cells. Inflammatory cells like 
eosinophils, neutrophils, histiocytes may be seen in the dermis.Type 
B(Lymphocytic): There will be epidermotrophic infiltrate of small to 
medium sized lymphoid cells.Type C(ALCL- type): There will be 
nodular infiltrate of large atypical lymphoid cells arranged in sheets. 
Inflammatory cells may be present. 
Differential diagnosis
122 
 The differential diagnosis includespityriasis lichenoides,arthropod 
reaction, pseuolymphoma and anaplastic large cell lymphoma. 
Treatment and prognosis
122 
 Topical ultrapotent corticosteroids for 2-3 weeks followed by 
weekly pulse is effective in clearing the lesions. Low dose oral 
methotrexate(5-10mg/week) will suppress the development of new 
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lesions. PUVA therapy has also been reported to have beneficial effect on 
the disease. There may be relapse of the lesions after discontinuation of 
the therapy. So, in patients with relatively few and non scarring 
lesions,long term follow up without active treatment should be 
considered. 
Prognosis  
 About 10-20% of adult patients will develop malignant  lymphoma 
and there is increased risk of developing non lymphoid malignancies. A 
study conducted in 35 paediatric patients with lymphomatoid papulosis 
showed that 9% of them developed non Hodgkins lymphoma,
122
 which 
emphasize the need for long term surveillance. 
 PAPULAR ACRODERMATITIS OF CHILDHOOD 
 Papular acrodermatitis of childhood was initially described by 
Gianotti in 1955.
123
Subsequently in 1956 Crosti and Gianotti described 
the entity and since then the disorder has been commonly as Gianotti 
Crosti syndrome. They described the disorder as symmetrical distribution 
of erythematous papular eruption over face, buttocks and extremities of 
children. 
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Epidemiology 
 Gianotti crosti syndrome is distributed world wide. The age group 
affected are 1-6 years with 90% being affected  before the age of 4 
years.
123
There is no specific gender or race predisposition. Adult cases 
are rarely reported. (Pac ) 
Aetiology 
124 
 The etiology of PAC has long been suspected to be viral in origin. 
The common viruses implicated are Ebstein Barr virus, cytomegalovirus, 
coxsackie virus, parvovirus B19,rotavirus, and HHV 6. A possible 
association withvaccines has also been suggested.  MMR vaccine, 
DPT,oral polio, hepatitis B vaccines are reported to be associated with 
PAC.Bacterial pathogens include Mycoplasma pneumoniae, 
Boreliaburgdorfei, Bartonnella henselae, groupA B-hemolytic 
streptococcus.  
 The exact mechanism of pathogenesis of PAC is not well 
understood. It may be due to a viral antigenemia and circulating immune 
complexes. 
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Clinical features
124 
 Papular acrodermatitis is seen predominantly in children between 
the age of 1and 6 years. There will be a history of upper respiratory tract 
infection in majority of the children. The eruption is characterised by  
monomorphous,erythematous, edematous papules and papulovesicles 
distributed symmetrically over face ,buttocks and extensor surface of 
upper and lower extremities. The papules may coalesce into large 
erythematous plaques. Lesions are usually non pruritic or mildly pruritic. 
It may take 8-12 weeks to resolve completely. Post inflammatory 
hypopigmentation may occasionally persist for several months. 
Diagnostic Criteria for Gianotti-Crosti Syndrome
123 
 Cuhh ATT proposed a diagnostic criteria for PAC. 
 A Patient is diagnosed to have Gianotti Crosti syndrome if he/she  
exhibits all positive clinical features on at least one occasion or clinical 
encounter, and does not exhibit any negative clinical feature on any 
occasion or clinical encounter related to rash, and no differential 
diagnosis is considered more likely than diagnosis of GCS based on 
clinical judgment, and if lesional biopsy is performed, findings are 
consistent with GCS 
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Positive Clinical Features 
1. 1.Monomorphous, flat-topped, pink-brown papules or 
papulovesicles  1–10 mm in diameter.Any 3 or all 4 sites 
involved: cheeks,   buttocks, extensor surfaces of  forearms, 
extensor surfaces of legs. 
2. Symmetry 
3. Duration of 10 days or more 
Negative Clinical Features 
1. Extensive truncal lesions 
2. Scaly lesions 
Differential diagnosis
125 
 Acrodermatitis enteropathica, erythema infectiosum, erythema 
multiforme, hand-foot-and-mouth disease,Henoch-Schönlein purpura, 
Kawasaki disease, lichen planus, papular purpuric gloves-and-socks 
syndrome, papular urticarial and scabies. 
Histopathology  
 Epidermis will show parakeratosis, focal spongiosis, and 
lymphocytes. There is a superficial and mid dermal perivascular infiltrate 
of lymphocytes and histiocytes. Sometimes the inflammatory infiltrate 
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may also present as lichenoid infiltrate. Papillary edema and 
extravasation of RBCs may also be seen.  
Treatment and prognosis 
 Gianotti crosti syndrome is a self limiting disease. Treatment is 
mainly supportive. In hepatitis B associated PAC, a self resolving 
anicteric viral hepatitis may evolve after 2 weeks of onset of eruptions 
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METHODOLOGY 
 
 The study was conducted in the outpatient department of 
dermatology, Coimbatore medical college hospital  between the time 
period of  August 2013 and July 2014. This is a clinical study of 
papaulosquamous disorders  in children less than 12years who were 
clinically diagnosed to have papulosquamous disorder as per ICD 10 
classification .Ethical committee clearance  was obtained. A written 
informed consent was obtained from the parents. 
Inclusion criteria : 
 All children less than 12 years who presented to the skin OPD with 
papulosquamous morphology of skin lesions. 
Exclusion criteria: 
 Children whose parents did not give consent for the study. 
 One hundred and five children were clinically diagnosed to have  
papulosquamous disorder during the study period. A detailed history 
including age of onset, duration of the disease, progression and associated 
symptoms were obtained from the patients and their parents. Relevant 
family history and history of drug intake prior to the onset of disease 
were recorded.General examination and systemic examination were done.  
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 Dermatological examination  was done. Morphology, distribution, 
characters of scales and  any special features were recorded. Hair, nails, 
oral and genital mucosa were examined in detail. 
 All routine investigations including haemoglobin, total blood 
count, differential count, erythrocyte sedimentation rate were done for 
each patient. 
 Special investigations like KOH mount,VDRL  and biopsy were 
done for relevant patients 
 Children from 0-12 years were divided into four groups. The 
findings were recorded in the profoma and tabulated in the masterchart. 
The results were analysed and discussed in detail. 
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RESULTS 
 One hundred and five patients under the age of 12 years with 
papulosquamous disorders attending the outpatient department of 
Dermatology,venereology and leperology , Coimbatore medical college 
hospital formed the study material.The duration of study was from 
August 2013 to July 2014. 
 During the study period of 1 year, 69445 patients attended the 
outpatient department, of which 12835 were children 
 
Table 4 No of total patients and pediatric patients attended the OPD  
Total number of 
patients attendedthe 
skin opd 
Total number of 
paediatric patients 
attended skin opd 
Percentage of 
paediatric patients 
attended skin opd 
69445 12835 18.48% 
 
 Out of the paediatric patients, 105 patients had papulosquamous 
disorders. 
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Table  5 Percentage of pediatric patients with  
papulosquamous disorder 
 
Total number of 
paediatric patients 
attening skin opd 
Total number of patients 
with papulosquamous 
disorders 
Percentage of 
papulosquamous 
disorder in children 
12835 105 0.81% 
 
SEX RATIO 
 Total number of patients included in the study were 105, out of 
which 55(52%) were male and 50(48%) were female.  
 
The male to female ratio in the study was 1.1:1 
 
AGE AND SEX DISTRIBUTION 
Table 6Age sex distribution of children with  
papulosquamous disorders 
Age( years) Male Female Total 
0-3 13 (23.64%) 11 (22%) 24 (22.86%) 
4-6 14 (25.45%) 11 (22%) 25 (23.81%) 
7-9 15 (27.27%) 12 (24%) 27 (25.71%) 
10-12 13 (23.64%) 16 (32%) 29 (27.62%) 
Total 55 (100%) 50 (100%) 105 (100.00%) 
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 Psoriasis was the most common papulosquamous disorder with 27 
cases (25.71%) ,followed by pityriasis rosea with 22 cases( 20.95%) and 
pityriasis lichenoides was the least common with 2 cases(1.9%). 
 
 The distribution of papulosquamous disorders in males and females 
in the study is as follows. 
 
Table 8Frequency of papulosquamous disorders  
in males and females 
Sl no Papulosquamous disorder Males Females 
1 Psoriasis 11(20%) 16(36%) 
2 Pityriasis rosea 10(18.18)% 12(24%) 
3 Lichen planus 12(21.82)% 7(14%) 
4 Seborrheic dermatitis 6(10.91)% 5(10%) 
5 Lichen striatus 6(10.91)% 5(10%) 
6 Lichen nitidus 3(5.45)% 1(2%) 
7 Pityriasis rubra pilaris 5(9.09)% 1(2%) 
8 Parapsoriasis 2(3.64)% 1(2%) 
9 Pityriasis lichenoiddes 2(3.64)% 0 
 TOTAL 55(100%) 50(100%) 
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Table 9Seasonal variation of papulosquamous disorders 
Disease 
Winter 
(Dec-Feb) 
Summer 
(Mar-May) 
Monsoon 
(June-Nov) 
Psoriasis  15 5 7 
Pityriasis rosea  11 5 6 
Lichen planus 5 9 5 
Seborrheic dermatitis 3 6 2 
Lichen striatus 4 5 2 
Pityriasis rubra pilaris 1 3 2 
Lichen nitidus 1 1 2 
Parapsoriasis  1 0 2 
Pityriasis lichenoides 1 1 0 
Total  42 35 28 
Percentage  40% 33.33% 26.67% 
 
 Incidence of papulosquamous disorder was high during the winter 
season(40%). 33.33% of patients visited during the summer season and 
26,67% of the patients visited during monsoon season. 
 The incidence of psoriasis(55.56%) and pityriasis rosea (50%) 
were more during the winter season.  
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PSORIASIS  
 In the study, out of 12835 patients ,psoriasis was reprted in 27 
patients. The prevalence of childhood psoriasis in the study is 0.21%. The 
prevalence of  childhood psoriasis among papulosquamous disorder is 
25.71%.  
 
 There were 11 boys and 16 girls with a male to female ratio of 
1:1.45 
AGE SEX DISTRIBUTION OF PATIENTS WITH PSORIASIS 
 The table shows the age sex distribution of psoriasis 
 
Table  10: Age sex distribution of patients with psoriasis 
Age(in years) Male Female Total 
0-3 1(9.09%) 2(12.50%) 3(11.11%) 
4-6 3(27.27%) 3(18.75%) 6(22.22%) 
7-9 5(45.45%) 2(12.50%) 7(25.93%) 
10-12 2(18.18%) 9(56.25%) 11(40.74%) 
Total 11(100%) 16(100%) 27(100%) 
 
  
 Age Sex
 
 The youngest 
of the children belon
of onset of psoriasis 
 Majority of th
group 7 to 9 years a
years. Mean age of o
in girls. 
 A patient with
psoriasis  gave hist
lesions. 
0
1
2
3
4
5
6
7
8
9
10
0-3
N
o
 o
f 
p
a
ti
e
n
ts
 
 
 
85 
CHART 5: 
 Distribution of Patients with Psoria
age of psoriasis in the study was 6 mo
ged to the age group 10-12 year(40.74
in our study was 6.83 years.  
e male patients with psoriasis belong
nd female patients belonged to the ag
nset of psoriasis in boys were 6 years
 guttate psoriasis and 2 patients with 
ory of fever and sore throat prior to
4 to 6 7 to 9 10 to12
Age in years
sis 
 
nths. Majority 
%). Mean age 
ed to the age 
e group 10-12 
 and 7.4 years 
chronic plaque 
 the onset of  
male
female
  A positive fam
patient gave  histor
father had history of 
 Pruritis was pr
Table No 11: Percen
 
Type of psoriasis 
Chronic plaque psori
Guttate psoriasis 
Flexural psoriasis 
Palmoplantar psorias
Pustular psoriasis 
Scalp psoriasis 
Total  
CHART 6:P
15%
11%
11%
7%
 
 
86 
ily history was present in 2(7.41%
y of psoriasis in the sibling and the 
psoriasis. 
esent in 16(59.25%) patients. 
tage of various morphological type 
Number of cases 
asis 14 
4 
3 
is 3 
2 
1 
27 
ercentage of morphological types of p
52%
4%
Chronic
Guttate
Flexural
Palmop
Pustular
scalp 
) patients, one 
other patients 
of psoriasis 
Percentage 
51.85% 
14.81% 
11.11% 
11.11% 
7.41% 
3.70% 
100.00% 
soriasis 
 plaque psoriasis
 psoriasis
 psoriasis
lantar psoriasis
 psoriasis
  
87 
 
 In this study chronic plaque psoriasis,14(51.85%) was the most 
common type of psoriasis seen in children .  
 Exclusive guttate psoriasis was seen in 4(14.81% ) children. But  
guttate lesion co existed with chronic plaque psoriasis in 7(25.92%) 
chidren. Pustular psoriasis was seen in 7.41% of children.   
 The nails were involved in 5(18.51%) cases. Pitting was the most 
common nail change.Other nail changes observed in the study are 
subungual hyperkeratosis and thickening of nail plate 
 Exclusive scalp psoriasis was seen only in 1(3.7%) patient  but 4 
(14.81%) patients had scalp lesions along with other site involvement. 
 Infantile psoriasis was present in 2(7.4%) children. 
  Koebnerisation was present in 12( 44.44%) patients.Auspitz sign 
was positive in all patients except the patients  with pustular psoriasis, 
flexural and palmoplantar psoriasis . 
 
PITYRIASIS ROSEA  
 In the study , pityriasis rosea was seen in 22 patients (20.95%).  
There were 10 male patients and 12 females patients with male to female 
ratio 0.83: 1.  
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 Herald patch was seen in 12(54.54%) patients and absent in10 
patients(45.46%).  Most common site of herald patch in the study was 
trunk. The median time between the appearance of herald patch and wide 
spread eruption was 1 week( range4 days-10days) 
 
Table 13: frequency of various types of PR 
 
Sl no 
Type of pityriasis 
rosea 
Number of 
patients 
Percentage 
1 Classical  18 81.81% 
2 Inverse  3 13.6% 
3 lichenoid 1 4.54% 
 
 Most common type of PR in the study was classical PR, seen 
in18(81.81%) patients.  Inverse type of PR was seen in 3(13.6% ) patients 
in the study  . Lichenoid PR was seen in 1 (4.54%) patient. 
 
 One(4.54%) patient had eczematous changes associated with PR 
lesions 
. 
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Table14:Site of involvement of pityriasis rosea 
Sites  No of patients Percentage 
Face 6 27.27% 
Neck 7 31.81% 
Chest  10 45.46% 
Back 18 81.81% 
Upperlimb 13 59.09% 
Lower limb 7 31.81% 
 
 In the study ,most common site affected was back(81.81%). 
Upperlimb lesions were seen in 12(59.09%) patients. Lowerlimb and 
neck lesions lesions were seen in 7 (31.81% )of patients. Least common 
affected site was face,6(27.27%) children. 
 
Lichen planus 
 During the study period  of 1 year,out of 12835 attended the OPD,  
19 children had lichen planus. Thus the prevalence of  lichen planus in 
children in our hospital was 0.14%.  Out of 105 patients with 
papulosquamous disorders 19(18.09%) patients had lichen planus.In the 
study,12(63.16%)were male and 7(36.84%) were female with male 
female ratio 1.7:1  
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Table15:Age sex  distribution of patients with lichen planus 
Age( years) Male Female Total 
0-3 1(8.33%) 0(0%) 1(5.26%) 
4-6 4(33.33%) 4(57.1%) 8(42.11%) 
7-9 5(41.67%) 1(14.28%) 6(31.58%) 
10-12 2(16.67%) 2(28.57%) 4(21.05%) 
Total 12(100%) 7(100%) 19(100%) 
 
 In the study youngest age of onset was 3 years and eldest was 11 
years. Maximum number of patients belonged to age group 7 to 9 years. 
 
Table16 : Percentage of morphological types of lichen planus  
Type No. of cases  Percentage 
Classical  11 57.89% 
Generalised 5 26.32% 
Linear 3 15.79% 
 
 The most common morphologic variant of LP was classical LP 
(57.89%). Five patients (26.32%) had generalised LP and 3(15.79%) had 
linear LP. Koebnerisation was seen in 68.42% 0f patients. 
 Nail involvement was seen in 3 patients(15.79%). Two patients ha 
thinning of nail plate and one patient had naildystrophy of finger 
nails.Oral mucosal involvement were seen in 4 patients.(21.05%). 
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Reticular pattern was seen in 3 patients and 1 patient had violaceous 
plaque  
SEBORRHOEIC DERMATITIS  
 
 Seborrheic dermatitis was seen in 11(10.48%) patients in the study. 
There were 6 boys(54.54%) and 5 girls(45.54%) with a male to female 
ratio of 1.2:1 
 
Table17:Age sex distribution of patients with seborrhoeic dermatitis 
Age in months Male Female Total 
0-2 4(66.66%) 1(20%) 5(45.46%) 
3-5 1(16.67%) 3(60%) 4(36.36%) 
6-8 1(16.67%) 1(20%) 2(18.18%) 
total 6(100%) 5(100%) 11(100%) 
 
 Among the children with seborrheic dermatitis, highest number of 
cases belonged to age group of 0-2 months. Youngest child was of age 1 
month and eldest was of age 7 months.  
 
 Five (45.45%) children had onset of their disease  before the age of 
2 months.  
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 Males had earlier age of onset as compared to females. Mean age 
of onset of disease in males is 2.6 months and in females is4.4 months. 
 
Table18:Site of involvement in seborrheic dermatitis 
 
Site No: of patients Percentage 
scalp 10 90.91% 
Face 5 45.46% 
Neck 3 27.27% 
Trunk 3 27.27% 
Intertrigenous areas 2 18.18% 
 
 In the study,10(90.91%) children with seborrheic dermatitis  had 
scalp involvement. Face was involved in 5(45.46%)  children. Neck and 
trunk were in involved in 3(27.27%) children and intertriginous area in 
2(18.18%.)Erythroderma was seen in one patient with seborrheic 
dermatitis 
LICHEN STRIATUS 
 Lichen striatus constituted 10.91% of all papulosquamous 
disorders in the study. There were 4males and 7 females. The male 
female ratio was 0.57:1 
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Table19:Age-sex distribution of patients with lichen striatus 
Age in years Male Female Total 
0-3 2(60%) 2(28.57%) 4(36.36%) 
4-6 0 2(28.57%) 2(18.18%) 
7-9 1(40%) 3(42.86%) 4(36.36%) 
10-12 1(40%) 0 1(9.10%) 
Total 4(100%) 7(100%) 11(100%) 
 
 In this study minimum age of onset was at 2 years and maximum at 
11years. Eight (72.72)% 0f the patients had associated pruritis. 
 All cases had unilateral distribution. 
 
Table20 :Site of distribution of lichen striatus 
Site No. of cases Percentage 
Face 2 18.18 
Trunk 2 18.18 
Upperlimb 3 27.27 
Lowerlimb 4 36.36 
 
 In the study,most common site of  involvement of  lichen striatus 
was lowerlimb,4(36.36%) patients followed by upperlimb, 3(27.27%) 
patients. Face and trunk were involved in 2(18.18%) patients. 
 One patient had eczematous change over the lichen striatus. 
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PITYRIASIS RUBRA PILARIS 
 In this study 6 children presented with pityriasis rubra pilaris, 
which accounts for 5.71% of papulosquamous disorder. There were 5 
males and 1female with male female ratio 5:1 
Table 21:Site of involvement and type of PRP 
 
Sl no Age/Sex Site of involvement Type 
1 3Yrs/Mch Chest, back, abdomen Type IV 
2 6yrs/Fch Chest,Abdomen, back Type IV 
3 8yrs/Mch Elbow, knees TYPE IV 
4 11yrs/Mch Chest, abdomen, back TYPEIII 
5 11yrs/Mch Chest,  abdomen, back TYPE IV 
6 11yrs/Mch Scalp. back, arms TYPE 1V 
 
 The youngest age of onset was 3 years and eldest age of onset was 
11 years. 
 In our study TypeIV PRP , was the most common type noticed. 
One patient had scalp involvement and 2(33.33%) patient had palms and 
soles thickening. 
 One child had lichen nitidus and one had associated lichen striatus 
along with PRP lesions. 
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LICHEN NITIDUS  
 Lichen nitidus   constituted 3.80% of all  patients with 
papulosquamous disorders in the study. There were 3(75%) males and 
1(25%)female with a male female to ratio of 3:1. 
Table 22 Site of involvement in lichen nitidus 
Sl.no Age in years Gender Site 
1 4 Mch Elbow 
2 6 Mch Forearm,genitals 
3 7 Fch Trunk, extremities 
4 9 Mch Elbow,forearm 
 
 Upperlimbs were the most common site of involvement in the 
study. Out of the 3 male patients 1 patient had classical LN  lesions over 
the genitals. 
 
 Koebner phenomenon was seen in 3(75%) patients.  
 One patient, 7 yrs old female child had generalised lichen nitidus 
 
PARAPSORIASIS 
 Parapsoriasis was seen in  3 patients(2.85%) in the study. There 
were 2 male and 1 female patient with male to female ratio of 2:1. 
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Table 23Site of involvement in parapsoriasis 
Sl no Age/sex Site of distribution 
1 11yrs/Fch Face, trunk, upper limbs and lower limbs 
2 11yrs/Mch face, trunk, upper limbs and lower limbs 
3 4yrs/Mch Tunk,upperlimb 
 
 All the three patients had small plaque parapsoriasis. The age of 
onset of the patients were 11 years,7 years and 3 years with mean age of 
onset of 7 years. Out of the 3 patients 2 patients had generalised 
involvement,including the face and 1 patient had lesions limited to trunk 
and upperlimbs. 
PITYRIASIS LICHENOIDES 
 In the study, pityriasis lichenoides constituted 1.9%(2 patients) of 
papulosquamous disorders. Both of them were male patients. 
 One patient had pityriasis lichenoides chronica and one patient had 
the acute form,PLEVA. 
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 8 year old male patient presented with hypopigmented and brown 
coloured scaly patches over chest, back and arms. Histopathological 
examination revealed features suggestive of pityriasis lichenoides 
chronica. 
 11 year old male patient presented with erythematous papules over 
chest and back, with central necrosis and mild scaling. There was history 
of fever prior to the onset of disease. Histopathological examination 
revealed features suggestive of PLEVA. 
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Fig. 4 Plantar Psoriasis 
 
 
    
             Fig. 5 Psoriasis – Nail   Fig. 6 Nail Pitting in Psoriasis 
 Fig. 8. Pustular Psoriasis 
    
    
 
 
 
101 
Fig. 7 Flexural Psoriasis  
 
          
  Fig. 9 Histopathology of P
  Showing Hyperkeratosis ,Parakeratosis,micro m
   Elongation of Rete ridges and Lymphocy
 
 
 
soriasis  
unro abscess, regular  
tes in the dermis 
  
102 
 
        
          Fig. 10 Pityriasis Rosea Fig.11  Herald Patch 
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Fig. 22 Lichen Stratitus - Upperlimb 
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106 
 
 
    
 
Fig. 25 Seborrhoeic Dermatitis-Scalp       Fig. 26  Seborrhoeic Dermatitis – Face 
            Yellow greasy scales 
 
 
 
Fig. 27 Seborrhoeic Dermatitis – Erythroderma 
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Fig 28 Pityriasis Rubra Pilaris – Type IV 
 
 
 
Fig 29 Pityriasis Rubra Pilaris – Type III 
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DISCUSSION 
  
 Dermatological disease forms an important part in the out patient 
attendance of paediatric population. Skin diseases in children are 
associated with significant morbidity and they form a major health 
problem in the paediatric age group. Skin diseases contribute to 30% of 
outpatient visits to paediatrician and 30% of patients consulting a 
dermatologist will be from paediatric age group.
126,127
  
 The prevalence of paediatric dermatoses  in various parts of India 
ranges from 8.7 to 35% in school based  surveys.
14
In the present study, 
hospital based prevalence of skin disease among children was 18.48%. 
Papulosquamous disorders constituted 0.81% of paediatric dermatosis in 
the present study. In an Indian study conducted in Rajasthan, 
papulosquamous disorders constituted 1.66% of paediatric dermatosis.
2
In 
a recent study from Turkey
128
 papulosquamous disorders constituted 
6.9% of all paediatric dermatosis and a similar study
129
 showed a 
prevalence of 14.2% among the paediatric dermatosis. 
 The difference in the prevalence rate may be due to the  short 
duration of the study and  geographical variations. 
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AGE -SEX DISTRIBUTION  
 In the present study male patients(52%) outnumbered the female 
patients(48%) with a male female ratio of 1.1:1which is similar to the 
study by Vetrichevvel etal,
130
 where boys (57.5%) outnumbered girls 
(42.5%). But in another study on papulosquamous disorders in children, 
females(54.9%) outnumbered males(45.1%)
131 
 In our study highest percentage of patients belonged to the age 
group. 10-12 years(27.62%). In Kalyani vasram vadite study, highest 
percentage of patients belonged to the age group 5-9 years.
131 
FREQUENCY OF VARIOUS PAPULOSQUAMOUS DISORDERS 
 In the present study, the various papulosquamous disorders seen in 
decreasing order of frequency were, psoriasis(25.71%), pityriasis 
rosea(20.95%), lichen planus(18.09%), seborrheic dermatitis(10.47%). 
Lichen striatus(10.47%), pityriasis rubra pilaris( 5.71%),lichen 
nitidus(3.8%) , parapsoriasis (2.85%) and pityriasis lichenoides(1.9%). 
 In a similar study conducted by Kalyani vasram vadite,
131
 the 
frequency of papulosquamous disorders in decreasing order were lichen 
planus(28.43%), pityriasis rosea(25.49%), seborrheic dermatitis(19.61%), 
psoriasis vulgaris(16.67%), lichen striatus(3.92%), pityriasis rubra 
pilaris(3.92%) and lichen nitidus( 1.96%). 
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 Vetrichevvel et al
130
 reported pityriasis rosea as the commonest 
disease in their study followed by lichen planus, seborrheic 
dermatitis(11.11%), psoriasis (11.1%), pityriasis rubra pilaris (10.2%), 
lichen nitidus(9.2%), lichen striatus (6.4%), pityriasis lichenoides 
chronica (2.7%), acrodermatitis enteropathica and drug induced 
erythroderma (one case each, 0.9%) and a total of 5 cases of 
erythroderma due to papulosquamous causes were noted. 
 An Egyptian study
132
 reported pityriasis rosea as the commonest 
disease  in papulosquamous disorder followed by psoriasis and and PRP . 
Psoriasis  
 During the study period of 1year, out of 12385 patients attended 
dermatology OPD 27 patients had psoriasis. Thus the hospital based 
prevalence of childhood psoriasis was 0.21%. This is comparable to the 
study conducted in Karnataka which showed a prevalence of 0.38%
131
and 
low as compared to a South Indian study in paediatric population which 
showed a prevalence of 1.4%.
14
 
 A study conducted in Saudi arabia by Ghada A. Ben Saif and Salha 
A. Al Shehab
3
 showed a prevalence of 1.8% among paediatric 
dermatosis. In a Turkish study
133
 and study by Gul et al
128
 showed higher 
prevalence of 3.8% and 5.4% respectively. 
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 In this study, among 105 patients with papulosquamous disorders, 
27(25.71%) were psoriasis. This is comparable to a study conducted in 
Saudi Arabia
3
 which showed a prevalence of 22.6% childhood psoriasis 
among the papulosquamous disorders. But Vetrichevvel et al
130
noted  a 
lower prevalence of 11.11% of childhood psoriasis among 
papulosquamous disorders. 
 In the present study females out numbered males with a male to  
female ratio of1: 1.45.Mercy et al
134
 reported a similar male to female 
ratio of 1:1.48 among childhood psoriasis where as kumar et al
18
 showed 
a male to female ratio of 1.09:1.A survey of 1262 childhood psoriasis in 
Australia
21
 reported a male to female ratio of 1:1. 
 The age of onset in our study ranged from 6 months to 12 years. 
Kumar et al
18
 reported age of onset from 4days to 14 years. 
 The mean age of onset in our study was 6.83years.In a study from 
Denmark
135
 mean age of onset of childhood psoriasis was 8.1 years which 
is slightly higher than the present study. Kumar et al
18
 reported a mean 
age of onset of 8.1±2.1 years in boys and 9.3±2.3 in girls. In the present 
study mean age of onset of psoriasis in boys was 6 years and 7.4 years in 
girls. So boys had an earlier age of onset than girls.  
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 In our study,the peak age of onset in males was 7 to 9 years where 
as in females, peak age of onset was 10-12 years. Kumar et al
18
 reported a 
peak age of onset of 6-10 years in males and 10-14 years in females. 
 Chronic plaque psoriasis was the most common presentation in our 
study(51.85%) as observed by various previous studies.
18,20,22,23 
Table 24Comparison of frequency of chronic plaque psoriasis in 
various studies 
Sl.no Author Place of study Percentage 
1 Nanda A et al
20 
Chandigarh ,India 69.6% 
2 Fan X et al
22 
China 68.6% 
3 Kumar et al
18 
India 60.6% 
4 Yan wu et al
23 
China 52.6% 
5 Present study coimbatore 51.85% 
 
 In contrast to the above studies, guttate psoriasis was the most 
common type observed in Denmark.
21
In the present study guttate 
psoriasis was seen in 14.81%. Nanda et al
20
 observed guttate psoriasis in 
25.9% of childhood psoriasis and Yan wu et al
23
 reported a frequency of 
25.5% of guttate psoriasis in china. 
 The palms and soles have been reported to be uncommon sites of 
psoriasisinvolvement in children. However, in our study, palmoplantar 
psoriasis was observed in 11.11% of patients. Kumar B et al
18
 reported 
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palmoplantar psoriasis in 12. 8% of childhood psoriasis. Morris et al
21
 
reported plantar psoriasis in 4% ,however Fan X et al
22
 did not observe 
plantar psoriasis in their study. 
 In our study,pustular psoriasis was observed in 7.41% of the 
psoriasis patients . Yan Wu et al
23
 observed in 10.90% of children with 
psoriasis.Seyhan M et al
136
 reported pustular psoriasis in 13.1% of  
childhood psoriasis. 
 In our study infantile psoriasis was present in 7.4% of the patients. 
In Kalyani vasram study
131
 infantile psoriasis was seen in 5.9% of 
patients with psoriasis 
 Nail involvement was seen in 5(18.52%) patients which is low as 
compared to Yan wu et al
23
,who reported 25.5%. Pitting was the most 
common finding in the study. 
 Variable familial incidence has been reported in various studies of 
childhood psoriasis which ranges from 9.8 to 89%.In our study family 
history was seen in 2(7.4%) patients. Kumar et al
18
 and Yan wu et al
23
 
reported a familial incidence of 4.5% an 8% in childhood psoriasis 
respectively. But a study conducted in United States by Mercy et al 
134 
showed a familial incidence of 51.4% in childhood psoriasis. 
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 Yan wu et al
23
 and Seyhan et al
136
 reported that upper respiratory 
tract infection was the most common triggering factor in childhood 
psoriasis. In our study precipitating factor was seen in 11.11% patients, 
which was upper respiratory tract infection in all the cases. 
 Pruritis was the most common symptom in our study(59.25%) 
kumar et al
81
 studies reported pruritis in.87.1% of the patients. 
Koebnerisation was seen in 12 patients (44.44%) which was higher than 
the observation in kumar et a1
8l
 study,which was 27.9%. 
 Psoriatic arthropathy and erythrodermic psoriasis were not 
observed in our present study.In a study from Karnataka
131
also  there 
were no cases of psoriatic arthropathy ans erythroderma.A north Indian 
study reported psoriatic arthropathy in 1.1% of their subjects. Mercy et 
al
134
study  reported psoriatic arthritis in 10.5% of all the subjects.Nanda 
et al
20
 study reported psoriatic erytroderma in 1.8% of their patients. A 
study from china
23
showed , psoriatic erythroderma in 5.1% of their 
patients. These study shows that prevalence of psoriatic erythroderma 
have regional and racial variation 
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Pityriasis rosea 
 Pityriasis rosea is an acute self limiting inflammatory 
papulosquamous disorder of unknown etiology. 
 In the present study .pityriasis rosea contributed 0.17% of all the 
paediatric dermatosis attending our skin OPD. A study from South India 
reported ,
14
 pityriasis rosea in 0.2% of  all the paediatric dermatosis. 
Another study conducted in north eastern region of India
94
 showed a 
frequency of 1.2%. but a study from Iraq
129
 showed a higher frequency of 
2.9% among children. 
 In a clinical study of papulosquamous disorders in children by 
Vetrichevvel et al
130
, pityriasis rosea was the most common 
disorder(32.4%) where as in our study PR was the second common 
condition seen in 20(22.95%) patients. This is comparable to a clinical 
study of papulosquamous disorders in children in Karntaka(25.49%)
130
. 
 In our stuy there were 10 males and 12 females with male to 
female ratio of 0.83: 1 which is similar to study conducted by Kalyani 
vasaram valdite
131
 with male to female ratio 0.7:1.In a clinical study on 
pityriasis rosea conducted by Egwin AS et al
137
 male to female ratio was 
1.5:1 and by Gunduz et al
138
 was 1.1:1 
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 The youngest age of pityriasis rosea in Andrew etal
139
 study was 3 
months old and 1 year in our study. 
 The maximum number of children with pityriasis rosea belonged to 
the age group 10-12 years(31.8%). Gunduz et al
138
 and kalyani vasram 
vadite
131
 observed peak incidence in 6-11 years age group with 49% and 
53.8% patients respectively 
 Seasonal variation has been found in pityriasis rosea. Gunduz et 
al
138
 and Kalyani Vasram Vadite
131
 observed a peak incidence during 
winter and autumn months. In our study peak incidence was during 
winter season(54.55%) similar to  the observation of Vetrichevvel et al.
130
 
 A history  of fever and sorethroat suggestive of upper respiratory 
tract infection was seen in 27.27% of patients.Gunduz et al
138
 observed 
prodromal symptoms in 33% of patients . 
 Pruritis was present in 16(72.72%) of the patients.Gunduz et al
138
 
observed pruritis in 69% of their patients. 
 Herald patch was seen in 54.46% of patients in our study, most 
common over the trunk with a median period between appearance of 
herald patch and widespread eruptions of  7days(4-12days). Gunduz et 
al
138
 study observed herald patch in 45% of patients, which was located 
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most often over the trunk. The median period between appearance of 
herald patch and widespread eruptions was 4 days(range 0-30 days). 
 Most common site of involvement in our study was back 81.81%. 
Least affected site in our study was face(27.27%) .In a clinical study by 
Kalyan vasaram valdite
131
, back was the most common site(88.5%) and 
neck was the least affected site(23.1%) 
 In our study,most common type of  pityriasis rosea was classical 
type(81.81%). Inverse PR was seen in 3 patients and lichenoid PR in 
4.54% of patients. 
 We have observed eczematous changes in 1(4.54%) patient with 
pityriasis rosea. 
Lichen planus  
 Lichen planus is a papulosquamous disorder of unknown 
etiology.Eventhough lichen planus is very rare in children,most reports of 
LP in children have come from the Indian subcontinent, suggesting that 
children of South Asian origin are more susceptible to developing 
LP.(lp7) The frequeny of lichen planus varies from 2.1% to 11.2% in the 
paediatric population. The prevalence of childhood lichen planus in 
children in our study was 0.15%. This is low when compared to study 
conducted by Handa et al
52
 in North India ,who reported 2.5% among the 
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total paediatric patients. A hospital based  study conducted at 
Iraq
129
showed , lichen planus formed 3.9% of the total number of 
paediatric dermatosis in a 6 month period. 
 In the study of  Vetrichevvel et al
130
 lichen planus constituted 
14.8% of various papulosquamous disorders where as in our study 
lichenplanus constituted 18.09%of the total papulosquamous 
disorders.Kalyani vasaram valdite
131
 reported a higher frequency of 
28.43% of lichen planus among the papulosquamous disorers. 
 Most of the studies show an equal sex prediliction in lichen planus 
or a slight male preponderance. Handa et al
52
 and Kalyani vasaram 
valdite
131
 reported a male female sex ratio of 1.1:1 . In our study the male 
female ratio was higher than these studies,ie; 1.7:1. Sharma and 
Maheswari
64
 have also reported a higher male female ratio of 2:1. 
 In our study, age group ranged from 3-12 years with mean age of 
onset of 6.6 years. In Handa et al
52
 study of  lichen planus in 87 children, 
the age group ranged from 8 months to 12 years with mean age of onset 
of 7.1 years. 
 The most common clinical type in our study was classical lp( 
57.89%) which is similar to Handa et 
a52
 and Sharma et al
64
 who observed 
classical LP in 60.9% and 60%of their LP patients  respectively. Linear 
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LP was observed in 15.79 patients in our study. Linear LP was observed 
from 8-30% in various studies
52,55,64.
One case of linear LP ha involvement 
of palms also.In our study we observed acute generalised LP in 26.32 % 
of all LP patients which is higher than Handa et al
52
 , who observed 6.9% 
and Sharma and Maheswari
64
 who observed 4%. 
 Various studies on childhood lichen planus had reported a 
frequency of 41-70% of involvement of extremities.
52,64,68
In our study, the 
most common site to be involved by lichen planus was 
extremities(78.95%), more commonly lower limbs. 
 Oral mucosal involvement in Lp ranges from 4.3 to 39% in various 
studies
52,64,140,
Oral mucosal involvement was  seen in 4 patients(21.05%) 
in our study which is comparable to Nnoruka et al
141
 who observed oral 
involvement in 23.1% of their patients. 
 In our study nail involvement was seen in  3 patients(15.79%). 
Kanwar and de
68
 observed nail involvement in 19.5% of their patients. 
But in other studies it ranges from 0-7.7%.
52,55,,64 
  Koebnerisation is seen commonly in childhood LP, which 
ranges from 24 to 28%.In our study we observed a higher percentage of 
koebnerisation of 68.42%. But Kanwar and 
68
 observed koebneriastion in 
only 6% of their patients. 
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 Pruritis was present in 84% of the patients in our study. This is 
comparable to findings of other authors who found pruritis in 87%, 
89.6% and 100% of their patients respectively.
64,68,142 
Lichen striatus 
 Lichen striatus is a self limiting papulosquamous disorder of 
unknown etiology in which ,the lesions follow the Blaschko lines. 
 Lichen stratus constituted 10.91% of all the papulosquamous 
isorders in our study, which is high as compared to the study of 
Vetrichhevel et al
130
 who observed lichen striatus in 6.4% children. 
 Lichen striatus is more common in females than in males. In our 
study male: female ratio was 0.57: 1 which is similar to Patrizzi et al
143 
who noted male to female ratio of 0.5:1. 
 Lichen striatus is more common in the age group 5-15 years.In our 
study maximum number of patients were seen in the age group0-3 years 
and 7-10 years with mean age of 5.5 years. Patrizzi et al
143
 reported a 
mean age of 4.5 years 
 In our study the most common site of presentation was 
extremities(63.63%); lower limb (36.36%) more than 
upperlimb(27.27%). This is similar to Taniguchi et al
144
 study in which 
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lesions were predominant in the lowerlimbs. In Patrizzi et al
143
 study, 
extremities were the most frequent site with no substantial difference 
between upperlimbs  and lower limbs were seen. Taieb et al
88
 study 
reported upperlimbs to be the most common site. 
 One patient with lichen striatus had eczematous changes. 
SEBORRHEIC DERMATITIS  
 In our study seborrheic dermatitis was seen in 11(10.48% ) 
patients. This is comparable to Vetrichevvel et al
131
 who noted seborrheic 
dermatitis in 11.11% of their patients with papulosquamous disorders. 
 Seborrheic dermatitis affects males more often than female 
children. In our study 54.54% of the cases were male and 45.45% cases 
were female with a male to female ratio of 1.2: 1.Wananukul et al
145
 
study also showed that 51.66% of the cases were male and 48.33% were 
male to female ratio was 1.06:1.But in Kalyani vasram vadite
130
 study 
females(55%) outnumbered males(45%) with male to female ratio of 
0.82:1 
 The youngest child was of age 1 month and eldest of age 7 months. 
Majority of the children belonged to 0-2 months age group. Wananukul et 
al
145
 also noticed 60% of the children were less than 2 months. 
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 In our study , the scalp (90.91%) was the most common site to be 
involved which is comparable to Foley et al
146
 and Kalyani vasram 
vadite
131
 study, where scalp involvement was seen in 86% an 95% of the 
children respectively. 
 Generalised seborrheic dermatitis was noted in 1 patient in our 
study who was a 2 year old male child. In a study, infantile seborrheic 
dermatitis constituted 10% of the causes of erythroderma
10
. 
 
PITYRIASIS RUBRA PILARIS 
 Pityriasis rubra pilaris is an idiopathic inflammatory 
papulosquamous disorder characterised by follicular hyperkeratosis, 
palmoplantar karatodema and erythroderma. In our study 6(5.71%) 
children presented with pityriasis rubra pilaris. Vetrichevvel et al
130
 noted 
pityriasis rubra pilaris in 10.92 % of the children in their study and 
kalyani vasram vadite noted 3.92% of the children in their study. 
 In our study mean age was 8 years, slightly higher than yang et al 
who reported mean age of 6.5 years in their study of 28 cases of juvenile 
pityriasis rubra pilaris. 
 The male to female ratio in our study was 5:1.  
 In our study Type IV ,juvenile onset circumscribed pityriasis rubra 
pilaris was the most common type  (83.33%) followed by type III. Yang 
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et al studies also reported a similar observation. There were no cases of 
type V PRP in our study. There were no case of erythroderma due to PRP 
in our study. 
Table 25Comparison of patients with juvenile pityriasis  
rubra pilaris in different studies 
Sl no: Present study Yang et al
147 
Gelmetti et al
148 
Number of cases 6 28 31 
Age of onset(in years) 3-11 0.67-18 2-13 
Type III 16.67% 14.33% 34% 
Type IV 83.33% 85.7% 66% 
Type V 0 0 0 
Site of involvement    
Scalp 16.67% 25% 32% 
Palms  33.33% 89% 84% 
Soles  33.33% 86% 84% 
Trunk 50% 39% 25% 
Elbows  66.67% 64% 77% 
Knees  50% 89% 77% 
Lichen nitidus 
 Lichen nitidus is a rare chronic papulosquamous disorder of 
uncertain etiology seen primarily in the paediatric population. In our 
study , 4(3.8%)  patients presented with lichen nitidus which is low when 
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compared to vetrichevvel et al
131
 who reported lichen nitidus in 9.2% of 
children. 
 In lichen nitidus, there is an equal male to female ratio or slight 
male predominance. In our study male to female ratio was 3:1 which is 
similar to Zapata et al
149
 study in which male to female ratio was 3:1. 
Lapins et al also reported a higher male to female ratio of 4:1. 
 In our study mean age of onset was 6.5 years . Mean age of onset 
of males was 6.1 years  which is comparable to Lapins
150
 study where 
mean age of onset was 7 years for males. Mean age of onset in female in 
lapins et al study was 13 years
150
. In our study only one female was 
noticed who was 7 years age old. 
 Extremities were the most common site of involvement in our 
study which is similar to kalyana vasram vadite study.. Zapata et al
149
 
noted upperlimbs and trunk to be the most common site of involvement in 
their study.  
Generalised lichen nitidus is a rare variant of lichen nitidus.In our study 
one  patient, 7 year old female had  generalised lichen nitidus. 
Parapsoriasis  
 Parapsoriasis is a group of  uncommon inflammatory disorders 
characterised by persistent scaly inflammatory eruptions. In our study 
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there were 3 (3.80%)cases of parapsoriasis.Vetrichevvel et al reported 
parapsoriasis in  There were 2 males and 1 female.All the three cases 
were of small plaque parapsoriasis. Out of the 3 patients ,2 patients had 
involvement all over the body including face and  1 patient had trunk and 
extremities involvement.  
Pityriasis lichenoids 
 Pityriasis lichenoies is a papulosquamous disorder of unknown 
etiology with acute and chronic presentations. 
 In our study, we noticed pityriasis lichenoides in 2(1.9%) patients 
Vetrichevvel et al
131
 also reported pityriasis lichenoides in 2.7% of the 
children with papulosquamous disease in their study. 
 Pityriasis lichenoides is more common in males. In various studies 
male to female ratio varies from 1.4:1 to 2:1.
151,152
 In our study   both of 
them were male patients. 
 One patient had pityriasis lichenoides chronica and the other had 
the acute form,PLEVA. 
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SUMMARY 
 A clinical study on papulosquamous disorders of children less than 
12 years was done from August 2013 to July 2014. The age-sex 
prevalence, age of onset, symptoms,morphology and site of involvement 
of lesions of each diseases were recorded, analysed and compared with 
other studies and discussed. 
 Papulosquamous disorders constituted 0.81% of the paediatric 
dermatoses during the study.Majority of the patients belonged to 
the age group10-12 years. The youngest patient was 1 year old at 
the time of presentation. Boys outnumbered girls with male to 
female ratio of 1.1:1 
 Psoriasis was the most common papulosquamous disorder 
(25.71%) followed by pityriasis rosea(20.95%). Pityriasis 
lichenoides was seen least in number(1.90%).Psoriasis patients in 
our study showed a female predominance with a male to female 
ratio of 1:1.45. Chronic plaque psoriasis was the most common 
type(51.85%).Guttate psoriasis was seen in (14.81%%)  of patients. 
Palmoplantar psoriasis was seen in 11.11%. Nail involvement was  
seen in 18.52% and scalp psoriasis in 3.7% .Pruritis  was seen in 
55.55% and Koebneriastion in 40.74% patients. 
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 Pityriasis rosea was seen in 22.95% patients, with male to female 
ratio of 1.5:1. It  was common in 10-12 years age group(31.8%) 
.Youngest patient was of age 1 year .Pruritis was seen in 72.72% 
patients.Herald patch was seen in  54.46% patient with most 
common site of involvement over the chest.Avaerage time period 
between appearance of herald patch and widespread eruptions was 
7 days.Most common type was classical PR seen in 81.81% 
patients. Inverse PR was seen in-13.6% and lichenoid PR was seen 
in4.54% patients. 
 Lichen planus was seen in 18.09% of the total 105 patients with 
male to female ratio of 1.7:1. Mean age of onset was 6.6years. 
Most common clinical type was classical LP(57.89%). Generalised 
LP was seen in 26.32% patients and linear LP was seen in 15.79% 
patients. Most common site involved was extremities(78.95%), 
more commonly lowerlimbs. Oral mucosal involvement was seen 
in 21.05% patients. Nail involvement was seen in 15.79%. pruritis 
was seen 84% of the patients and koebnerisation in 68.42% 
patients. 
 
  
130 
 
 Seborrheic dermatitis was seen in 10.48% of patients with male to 
female ratio of 1.2: 1. Children with seborrheic dermatitis belonged 
to 1 months and 7 months. Majority of children belonged to 0-2 
months age group. Most common site to be involved was 
scalp(90.91%). Erythroderma was present in 1 patient. 
 Lichen striatus constituted 10.48% of patients with 
papulosquamous disorders with male to female ratio of 0.5:1. Mean 
age of onset was 5.5 years. Most common sites involved were 
extremities.Most common pattern observed was linear pattern. 
 Pityriasis rubra pilaris was seen in5.71% of the patients with male 
to female ratio of 5:1.Most common type of PRP noticed was Type 
IV(83.33%). Most common sites observe was elbows(66.67%). 
Palms and soles were involved in 33.33% of patients an scalp was 
involved in16.67% 
 Lichen nitidus was seen in 3.8% of patients with male female ratio 
of 3:1. Most common site involved was extremities.One of the 
three male patients  had typical lesions over genitalia. Generalised 
lichen nitidus was seen in one patient. 
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 Parapsoriasis was seen in 2.85% of patients in the study. All the 
patients had small plaque parapsoriasis. The mean age of onset of 
parapsoriasis in our study was 7 years. Two patients had 
generalised involvement including the face. One patient had 
distribution of the lesions over the trunk and upperlimbs. 
 Pityriasis lichenoides was seen in 21.9% of the patients. One 
patient had pityriasis lichenoides chronica and one patient had 
PLEVA. In our  study,all the patients were male. 
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CONCLUSION 
 Papulosquamous disorder is a common dermatological group of 
disorders which is more predominant in male children . Various factors 
like age, gender and seasonal variation play a role in the occurrence and 
exacerebration  of these group of disorders. Genetic  inheritance  plays  
negligible role in the occurrence of these disorders. The prevalence rate 
of papulosquamous disease varies from region to region. This regional 
variation can be due to the climatic and racial variation.  
 The prevalence of papulosquamous disorders in our study was 
0.81%. The most common papulosquamous disorder in the study was 
psoriasis 
 Understanding the morphology , distribution  of the lesions, 
characteristics of the scales and special features like koebnerisation, 
Auspitz sign, herald patch etc will help to differentiate the individual 
diseases clinically. This will  avoid invasive procedures like biopsy 
particularly in paediatric age group, as the patients and the parents will be 
anxious . When it is difficult to differentiate the diseases clinically, 
biopsy and histopathological examination will come in hand. Individual 
diseases in this group have variable prognosis.. 
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By understanding the morphological characterestics of papulosquamous 
diseases and differentiating the diseases clinically ,we can  explain the 
prognosis of the disease to the parents, which will alleviate their worry.  
LIMITATION OF THE STUDY: 
 As the study  was of short duration, follow up and response to 
treatment could not be evaluated. 
 Natural course of the disorders could not be studied as the study 
was of short duration. 
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APPENDIX 1 
PROFORMA 
 
Name:………………….....................Sl. No:……………… 
Age:…. OP No…………….... 
Sex -M/F Date:……………….. 
Informant:…………..: 
Address:  
PRESENTING COMPLAINT :- 
H/o skin lesions 
H/o itching 
H/o other symptoms 
HISTORY OF PRESENTING ILLNESS : 
SKIN LESIONS 
Mode of onset :Sudden/Rapid/Insidious 
Distribution : 
Itching : Mild/Moderate/Severe 
Seasonal Variation 
Aggravating / Relieving factors 
Remissions / Exacerbations 
OTHER SYMPTOMS:Fever/joint pain/others 
OTHER SITES: 
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Treatment History:Topical/ Systemic/ Others 
Past History :Similar illness / Any other contributing illness 
Family History :Similar illness / Any other contributing illness. 
Personal History :Diet:Veg / Mixed 
Appetite – Good / reduced 
Sleep – Sound /disturbed 
Bowel – Regular / irregular 
Bladder – Regular /variability. 
EXAMINATION : 
General Physical Examination: 
Height: Weight: 
Temp: Febrile / Afebrile. Resp Rate- / min 
Pulse: / min. BP- mmHg 
Built: Poor / Moderate / Well. 
Nourishment: Poor / Moderate / Well 
Cyanosis: Present / Absent Icterus: Present / Absent Pallor: Present 
/Absent 
Pedal oedema: Generalised Lymphadenopathy: 
Cutaneous Examination ; 
Types of Lesions: 
Pattern: 
Distribution: Symmetrical / Asymmetrical 
Scales : Fine/ Coarse 
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Colour 
Size 
Adherence: Loosely/ Firmly 
Special characters:  
OTHER SITES  
Palms 
Soles  
Hairs  
Nails 
Mucosa membrane: Conjunctival /Genital/Oral/ Anal/Nasal 
Systemic Examination :- 
 P/A  
RS 
CVS 
 CNS 
Provisional Diagnosis: 
Associated diseases if any: (A) Cutaneous (B) Systemic 
Investigations  
Blood: Hb% -   TC-DC-ESR- 
Urine routine  KOH 
Skin biopsy 
FINAL DIAGNOSIS:  
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CONSENT FORM 
 
 Dr. Preetha Prasad, post graduate  student  in  the  Department of 
Dermatology, Venereology  and  Leprosy, Coimbatore medical college 
hospital  is conducting  a  study  on “A  CLINICAL STUDY ON 
PAPULOSQUAMOUS DISORDERS IN CHILDREN LESS THAN 
12 YEARS”. The study  and  test procedures  were  explained to  me  
clearly. I hereby give my consent to participate my child in this study and 
to give blood sample and  to take  biopsy  if  needed. The data obtained 
herein  may be used  for  research  and  publication. 
 
Place: 
Date:       Signature of  the Parent 
                                                                       (Name:                             )                 
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xg;g[jy;  gotk;; [ ; ;; [ ; ;; [ ; ; 
bgah; : 
ghypdk; :      taJ : 
Kfthp : 
 
 muR nfhit kUj;Jtf; fy;Y}hpapy; njhy; kUj;Jt 
Jiwapy; gl;l nkw;gog;g[ gapYk; khztp mth;fs; nkw;bfhs;Sk; 
"FHe;ijfSf;F brjpy; cwpjy; neha ;" Fwpj;j Ma;tpy; bra;Kiw 
kw;Wk; midj;J tptu';fisa[k; nfl;Lf; bfhz;L vdJ 
re;njf';fis bjspt[g;gLj;jpf; bfhz;nld; vd;gij bjhptpj;Jf; 
bfhs;fpnwd;. 
 ehd; ,e;j Ma;tpy; vd; FHe;ijia ghpnrhjid bra;a KG 
rk;kjj;JlDk;/ Ra rpe;jida[lDk; fye;J bfhs;s 
rk;kjpf;fpnwd;. 
 vd; FHe;ijf;fhf bra;a[k; ,e;j Ma;tpy; vd;Dila 
midj;J tpgu';fs; ghJfhf;fg;gLtJld; ,jd; Kot[fs; 
Ma;tpjHpy; btspaplg;gLtjpy; Ml;nrgid ,y;iy vd;gij 
bjhptpj;Jf; bfhs;fpnwd;. ve;j neuj;jpy; ,e;j Ma;tpypUe;J ehd; 
tpyfpf; bfhs;s vdf;F chpik cz;L vd;gija[k; mwpntd;. 
 
,lk;  :      ifbahg;gk; / nuif 
ehs; : 
 
  
  
160 
 
KEY TO MASTER CHART 
 
Sl No - Serial number 
yrs -  Years 
m - months 
F - Female 
M - Male 
Fe - Fever 
ST - Sore throat 
Oz - Oozing 
Pu - Papule 
Pl - Plaque 
Pa - Patch 
Ma - Macule 
Fs - Fissure 
Ps - Pustules 
A - Annular 
L - Linear 
Pf - Perifollicular 
G - Grouped 
W - White 
Fi - Fine 
SW - Silvery white 
PC - Peripheral collarete 
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Y - yellow 
Gr - Greasy 
Th - Thickened 
As - Auspitz sign 
Kb - Koebnerisation 
Hp - Herald patch 
PV - Psoriasis vulgaris 
GP - guttate psoriasis 
FP - Flexural psoriasis 
SP - Scalp psoriasis 
PPS - palmoplantar psoriasis 
FP - flexural psoriasis 
PUPS - Pustular Psoriasis 
PR - Pityriasisrosea 
LP - Lichen planus 
GLP - generalised LP 
LLP - Linear lichen planus 
SD - seborrhoeic dermatitis 
LS - Lichen striatuus 
PRP - Pityriasis rubrapilaris 
LN - Lichen nitidus 
PLEVA - pityriasis lichenoides et varioliformis acuta 
PLC - pityriasis lichenoides chronic 
PaPS - Parapsoriasis 
SL 
No. 
NAME Age/Sex 
     
CLINICAL FEATURES 
DIAGNOSIS  
HISTORY MORPHOLOGY 
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1 Rani 5yrs/F 4yrs february + - - Pu,Pl A - - + + - + + - - - - + - - + SW AS.Kb PV 
2 Eeswari 6yrs/f 6yrs December - Fe - pa,pu - - + - - - + + - - - - - - - + PC HP PR 
3 Amritha 3m/F 3m March - - - pa - - + - - - - - - - - - + - - + Y,Gr Kb SD 
4 Parvathi 4yrs/F 4yrs April + - - pu,pl L - - - - - - + - - - + - - - + Fi,W Kb LLP 
5 Maari 11yrs/F 11yrs March + - - pa A + - - - + + + - - - - - - - + PC - PR 
6 Goutham 5yrs/M 4yrs December + - - pu - - - + + + - - - - - - - + - + Fi,W Kb LP 
7 Raman 11yrs/M 12yrs January + - - pu L - + - - - - - - - - - - - - + Fi - LS 
8 Pavithra 11yrs/F 12yrs January + 
 
+ Pl A - - - - - + + - - - + + - - + SW AS,Kb PV 
9 Sankar 7yrs/M 7yrs february + - - pu L - - - - + - - - - - - - - - + Fi - LS 
10 Roja 8yrs/F 7yrs March + - - pu L - - - - - + + - - - - - - - + Fi Kb LLP 
11 Bharath 8yrs/M 7yrs October + - - pu - - - - - - + + - - - - - - - 
+ 
+ 
Fi                                
Fi 
- 
PRP                                                                                               
LN 
12 Aaditya 5yrs/M 5yrs April - - - pa A + + + - + - - - - - - - - - + PC HP PR 
13 Jaiharini 8yrs/F 8yrs February + - - pu,pl A - - + + + + - - - - - - - - + PC HP PR 
14 Sabira 11yrs/F 11yrs December + Fe - Pu,Pl - - - + - - + - - - - - - - - + SW AS,Kb GP 
15 Jennifer 7yrs/F 5yrs December + - - PU - - - - - - - - - - - - - - - + SW AS,Kb GP 
16 Arun 6yr/M 6yrs December - - - pu G 
 
- - - - + - - - - - - - - + Fi - LN 
17 Chithra 7yrs/F 7yrs September + oz - pu L,G - - - - + - - - - - - - - - + Fi - 
LS with 
Eczema 
18 Thilakaraj 5yrs/M 4yrs May + - - pu,pl - - - - - - + + + - - - - + - + Fi Kb GLP 
19 Kaasi 4yrs/M 4yrs May - - - pa - + + + - - - + + - - - - - - + PC - IPR 
20 Vaani 11yrs/F 11yrs January + Fe - Pl A - - - - - - + - - + + - - - + SW AS PV 
21 Paramjothi 3yrs/M 3yrs December - - - pu A - - + - + + - - - - - - - - + Fi - PRP with LS 
22 Kabil 10yrs/M 8yrs January + - - pu,pl - - - - - - + + - - - - - - - + Fi Kb LP 
23 Thanushri 6yrs/F 5yrs December + - - Pu,Pl A - - - - - + - - - + - + - - + SW AS, Kb PV 
24 Nageswari 6m/f 6m March - - - Pl - - - - - - - - + - - - - - - - - - FP 
25 Manimekala 3yrs/F 3yrs December + - - pu L - - - - - - + - - - - - - - + Fi - LS 
26 Harish 9yrs/M 9yrs january - 
Fe, 
ST 
- pu,pa - - - - - + - - - - - - - - - + PC Ez PR 
27 Ilakiya 11yrs/F 10yrs September + - - Pu,Pl A - - + - + + + - - - + - - - + SW AS,Kb PS 
28 Ganesh 11yrs/m 11yrs March - Fe - pa - - - + + + - - - - - - - - - - - - PLEVA 
29 Kavitha 5yrs/F 5yrs
30 Malathi 5yrs/F 5yrs
31 Padma 7yrs/F 7yrs
32 kalayarasi 6yrs/F 6yrs
33 Ramkumar 4m/M 4m
34 Gunasekar 8yrs/M 7yrs
35 Suresh 11yrs/M 10yrs
36 Gaurav 4yrs/M 4yrs
37 Mathiyan 4yrs/M 4yrs
38 Paimala 8yrs/F 6yrs
39 Anandi 11yrs/F 10yrs
40 karthik 11yrs/M 11yrs
41 Poorni 4yrs/F 4yrs
42 Loganathan 9yrs/M 9yrs
43 Pandi 2yr/M -
44 Maalavika 6yrs/F 6yrs
45 Poomani 2yrs/F 2yrs
46 Madhan 8yrs/M 7yrs
47 Rajeswari 10yrs/F 10yrs
48 Ramalingam 8yrs/M 8yrs
49 Priya 11yrs/F 11yrrs
50 Vasudev 8yrs/M 7yrs
51 Thangavel 4yrs/M 4yrs
52 Vaishnav 8yrs/M 7yrs
53 Saavanth 9yrs/M 4yrs
54 Vasanthi 9yrs/F 9yrs
55 Aadiraj 3yrs/M 3yrs
56 Selvi 8yrs/F 8yrs
57 Arjun 11yrs/M 11yrs
58 Madhusri 11yrs/F 11yrs
59 Lekshmi 10yrs/f 9yrs
60 Thayyal 7yrs/F 7yrs
61 Ajith 4yrs/M 3yrs
62 Muthu 2yrs/M 2yrs
63 Anitha 11yrs/F 11yrs
64 Narmada 7yrs/F 6yrs
65 Lakshman 11yrs/M 11yrs
66 Janani 10yrs/F 9yrs
67 Rahul 12yrs/M 12yrs
 April + - - 
 february - - - 
 february + - - 
 March - - - 
 April - - - 
 february + - - 
 April + - - 
 June - - - 
 october - - - 
 May + - - 
 February + - - 
 August - - - 
 March - - - 
 December - - - 
 April + - - 
 June + - - 
 November - Fe - 
 February + Fe + 
 January + - - 
 April + - - 
 March - Fe,ST - 
 December + - - 
 April - - - 
 February - - - 
 September - - - 
 february + - - 
 May + - - 
 May + - - 
 July - - - 
 May - 
Fe, 
ST 
- 
 January - - - 
 December + - - 
 January + - - 
 March + - - 
 December + - - 
 October + - - 
 May - - - 
 December - - - 
 February - - - 
Pl - - - - - 
pu L - - - - 
pa A - - + + 
pu G,Pf - - - - 
pa - - + + - 
pa - - - + + 
pu G,Pf - - + + 
PL,Fs L - - - + 
Pl,Fs - - - - - 
Pu,Pl A - - - - 
Pu,pl - - - - - 
Pl,Fs - - - - - 
Pu L - - - - 
pu,pl - - - + 
 
pu G,L - - - - 
pu,pl - - - + + 
pu,pa A - - - - 
Pl,F - - - - - 
Pa A - - + + 
Pu - - - + + 
pu,pa - + + + + 
Pu - - - - - 
pu - - - - - 
Pu,Pl A - - - 
 
pu - - - - - 
pu,pl - - + - - 
pu - - - + - 
pu L - - - - 
Pl - - - - - 
pu,pa - + + - - 
Pu,Pl - - - + + 
pa A - - - + 
pu,pl - - - - - 
Pu L - - - - 
Ma,Pa - - + + + 
Pa - - - + + 
Pl,pu G,Pf - - - - 
Pl - - - - - 
Pu,Pa - - - - - 
- - - - - - - 
- + - - - - - 
+ + - - - - - 
- + + - - - - 
- - - + - - - 
+ - - - - - - 
+ + + - + + - 
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- - + - - - - 
+ + + - - - - 
+ + + - - - - 
+ + - - + + - 
- - - - - + - 
+ - - - - - - 
+ - - + SW AS 
- - - + Fi - 
- - - + PC HP 
+ - - + Fi - 
+ - - + Y,Gr - 
- - - + Fi,Br - 
- - - + Fi - 
- - - + Th Fi - 
- - - + Th - 
+ - - + SW AS.Kb
- - - + Fi Kb 
- - - + Th - 
- - - + Fi - 
- - - + Fi - 
- - - + Fi - 
- - - + Fi Kb 
- - - + PC - 
- - - + Th SW AS 
- - - + PC HP 
- - - + SW AS,Kb
- - - + PC - 
- - - + SW AS 
- - + + Fi - 
- - - + SW AS, Kb
- - - + FI Kb 
- - - + PC HP 
- + - + Fi Kb 
- - - + Fi - 
- - - + Fi - 
- - - + PC - 
- - - + SW - 
- - - + PC HP 
- - - + Fi - 
- - - + Fi - 
- - - + Fi - 
- - - + Fi kb 
- - - + Fi 
 
- - - + Th - 
- - - + PC - 
SP 
LS 
PR 
PRP 
SD 
PLC 
PRP 
PPS 
PPS 
 PV 
LP 
PPS 
LS 
LP 
LS 
GLP 
PR 
PV 
PR 
 GP 
PR 
GP 
LN 
 PV 
LN 
PR 
LP 
LS 
FP 
IPR 
PUPS 
PR 
LP 
LS 
PaPS 
LN 
PRP 
PPS 
PR 
68 Pradeep 11yrs/M 7yrs February - - - Ma,Pa - + + + + + + + - - - - - - - + Fi - PaPS 
69 Satheesh 8yrs/M 7yrs March + - - pu,Pl - - - - + + + + - - - - - - + + Fi Kb GLP 
70 Maalini 10yrs/F 9yrs May + - - Pl,Fs - - - - - - - - - - + - - - - + Th - PPS 
71 Balamurugan 6m/M 6m May - - - Pl - - - - - - - - - - - - + - - + Y,Gr - SD 
72 Charles 8yrs/M 7yrs February + - - Pu,Pl A - - + - + + - - - - - - - - + SW AS,Kb PV 
73 Dhanesh 9yrs/M 9yrs July + - - Pu,Pl - - - - - - + + - - - - - - - + Fi Kb LP 
74 Ramya 8yrs/F 8yrs April + - - Pu L - + - - - - - - - - - - - - + Fi - LS 
75 Veni 8m/F 8m January - - - Pl - - - - - - - + + - - - - - + + - - FP 
76 Jagadeep 11yrs/M 11yrs September - - - Pu G,Pf - - + + + - - - - - - - - - + Fi - PRP 
77 Dhanesh 10yrs/M 8yrs September + - - Pu L - - - - - + - - - - - - - - + Fi KB LLP 
78 Gauri 4yrs/F 4yrs October - - - Pa A - - - - + - - - - - - - - - + PC HP PR 
79 Krithika 5yrs/M  4yrs October + - - Pu,Pl - - - - - - + + - - - - - - - + Fi kb LP 
80 Sahaana 4yrs/M 3yrs October + - - Ma,Pa - - - + - - + - - - - - - - - + Fi,W - PaPS 
81 Vishnu 3m/M 3m october - - - Pl,Pa - - - - - - - - - - - - + - - + Y,Gr - SD 
82 Junaidh 2yrs/M 2yrs january + - - Pa - - - - - + + - - - - - - - - + PC - PR 
83 Revathi 6yrs/F 6yrs November - - - Pa,Pl - - - - - - + + - - - - - - - + Fi - LP 
84 Bharath 4yrs/M 4yrs September - - - Pa A - - - - + + - - - - - - - + PC HP PR 
85 Lakshan 3m/M 3m September - - - Pa - + + + - + + + - - - - + - - + Y,Gr - SD 
86 Kapilan 11yrs/M 12yrs December + - - Pa A + - + - + - - - - - - - - - + PC - PR 
87 Dharani 6m/F 6m March - - - Pl - + - - - - - - - - - - + - - + Y,Gr - SD 
88 Madhav 6yrs/M 5yrs July - - - Ps,Pl A - - - - + + + - - - - - - - - - - PUPS 
89 Balaji 11yrs/M 11yrs February - - - Pa A - - + - + + - - - - - - - - + PC HP PR 
90 Mithila 5m/F 5m April - - - Pa - - - - - - - - - - - - + - - + Y,Gr SD 
91 Anusree 11yrs/F 11yrs April + - - Pu,Pl - - - + + + - + - - - + - - - + Fi Kb GLP 
92 Iqbal 2m/M 2m May - - - Pa - - + - - + - - - - - - + - - + Y,Gr - SD 
93 Stalin 5yrs/M 5yrs May + - - Pl - - - - + - + - - - - - - - - + Fi kb LP 
94 Katherine 6m/F 6m January - - - Pa - - - - + - - - - - - - + - - + Y,Gr - SD 
95 Saranya 10yrs/F 10yrs January + - - Pu,Pl A - - - - - + + - - - - - - + SW AS,Kb PV 
96 Saravanan 9yrs/M 8yrs April - - Pl - - - - - - - + - - - - - + - + Fi - LP 
97 Babu 7m/M 7m December - - - Pa - + - - - - - - - - - - + - - + Y,Gr - SD 
98 Ali 1yr/M 1yr August + - - Pa - - - - - + - + - - - - - - - + PC - LPR 
99 Alice 11yrs/F 10yrs December + - - Pu,Pl A - - - - + + + - - - - - - - + SW AS,Kb PV 
100 Parveen 9yrs/F 9yrs March + - - Pu,Pl - - - - - - + + - - - - - - - + Fi - LP 
101 Meena 3yrs/F 3yrs July + Fe - Pa - + - + - + + - - - - - - - - + PC HP PR 
102 Sankar 10m/M 10m November - - - Pl - - - - - - - + - - - - - - + W - FP 
103 Gayathri  2yrs/F 2yrs November - - - Pu L - - - - - + - - - - - - - - + Fi,W - LS 
104 venkat 7yrs/M 7yrs June - - - Pa - - - + + - + - - - - - - - - + PC HP PR 
105 Kala 4m/F 4m January - - - Pa - - + + - - - - - - - - - - - + Y,Gr - SD 
 
 
